Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             858 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormally High Levels of Inflammatory Markers in Recipients of Continuous Flow Left Ventricular Assist Devices Grosman-Rimon, L.
 2013
 32 4S p. S282-
1 p.
 artikel
2 ABO-Incompatible Heart Transplantation: Necessity or Possibility? Gautier, S.
 2013
 32 4S p. S261-
1 p.
 artikel
3 Accuracy of a New Method for Semi-Quantitative Assessment of Right Ventricular Ejection Fraction by Cardiac MRI: Right Ventricular Fractional Diameter Changes Vermes, E.
 2013
 32 4S p. S204-
1 p.
 artikel
4 A Comparison between HeartMate II and HeartWare LVAD, a Single Center Experience Morshuis, M.J.
 2013
 32 4S p. S57-S58
2 p.
 artikel
5 Acquired Aortic Insufficiency with 2nd Versus 3rd Generation Continuous Flow Left Ventricular Assist Device Spiegelstein, D.
 2013
 32 4S p. S225-
1 p.
 artikel
6 Acuity Adaptable Patient Care Unit Shortens Length of Hospital Stay after Ventricular Assist Device Placement Osaki, S.
 2013
 32 4S p. S227-S228
2 p.
 artikel
7 Adaptation over a Wide Range of Donor Graft Lung Size Discrepancies in Living-Donor Lobar Lung Transplantation Chen, F.
 2013
 32 4S p. S119-
1 p.
 artikel
8 Adjusting N-Terminal Pro-Brain Type Natriuretic Peptide Levels for Ventricular Mass Improves Prediction of Right Atrial Pressure and Cardiac Index in Patients with Pulmonary Arterial Hypertension Raina, A.
 2013
 32 4S p. S252-
1 p.
 artikel
9 Adolescence and Transition to Adult Services: Are These Risky Times for Heart and/or Lung Recipients? Wray, J.
 2013
 32 4S p. S194-S195
2 p.
 artikel
10 Adolescent CF Lung Transplant Recipients Have Decreased Survival When Compared to CF Lung Transplant Recipients in Other Age Groups Goldfarb, S.B.
 2013
 32 4S p. S150-
1 p.
 artikel
11 Advanced Heart Failure Therapy in HIV Positive Patients: Do These Patients Get Equal Treatment? Uriel, N.
 2013
 32 4S p. S142-S143
2 p.
 artikel
12 Adverse Events (AEs) Associated with Everolimus (EVR) or Mycophenolate Mofetil (MMF) in De Novo Heart Transplant (HTx) Recipients: Results from the North American (NA) Subpopulation of Study A2310 Eisen, H.
 2013
 32 4S p. S200-S201
2 p.
 artikel
13 Age and Era-Based Survival Differences in Thoracic Transplantation Patients Who Require ECMO Law, S.
 2013
 32 4S p. S25-
1 p.
 artikel
14 Age Is No Boundary to Long Term Survival on Permanent MCS: A Multicentre Experience Tarzia, V.
 2013
 32 4S p. S284-S285
2 p.
 artikel
15 Aggregate Annual Health Care Expenditures Associated with Heart Transplantation in the United States: 1980-2011 Evans, R.W.
 2013
 32 4S p. S159-
1 p.
 artikel
16 Airway Complications after Lung Transplantation: Incidence, Risk Factors, Management and Outcome de Reus, Y.
 2013
 32 4S p. S265-
1 p.
 artikel
17 Alemtuzumab Induction Facilitates Steroid-Free Immunosuppression in Human Cardiac Transplantation: Five Year Outcomes Teuteberg, J.J.
 2013
 32 4S p. S199-
1 p.
 artikel
18 Allomap Gene Expression Profiling In Lieu of Routine Endomyocardial Biopsy (EMB) at 6 Months Post Transplant Thomley, A.M.
 2013
 32 4S p. S40-S41
2 p.
 artikel
19 Allosensitization in Children Supported with Ventricular Assist Devices Jeewa, A.
 2013
 32 4S p. S290-
1 p.
 artikel
20 Alpha-1 Proteinase Inhibitors Post-Lung Transplantation: A Single Center Experience Ravichandran, B.R.
 2013
 32 4S p. S295-
1 p.
 artikel
21 Alternative Approaches for the Surgical Treatment of Significant Mitral Regurgitation in Advanced Heart Failure Ganapathi, A.M.
 2013
 32 4S p. S283-
1 p.
 artikel
22 Analysis of Informed Consent for Heart Transplantation or Left Ventricular Assist Device Implantation MacIver, J.
 2013
 32 4S p. S126-
1 p.
 artikel
23 An Analysis of the Characteristics of Lung Transplant Patients That Develop Heparin Induced Thrombocytopenia Type II (HIT) after Transplant Ataya, A.
 2013
 32 4S p. S268-
1 p.
 artikel
24 A New Lung Preservation Technique through Bronchial Artery Perfusion on Ex-Vivo Lung Tanaka, Y.
 2013
 32 4S p. S300-
1 p.
 artikel
25 A New Program of Living-Donor Lobar Lung Transplantation Date, H.
 2013
 32 4S p. S217-S218
2 p.
 artikel
26 A New Universal Wireless Transcutaneous Energy Transfer (TET) System for Implantable LVADs – Preliminary In Vitro and In Vivo Results Kassif, Y.
 2013
 32 4S p. S140-S141
2 p.
 artikel
27 An Improvement in Peripheral Endothelial Function Six Months after Heart Transplantation Is Associated with a Lower Incidence of Coronary Allograft Vasculopathy Farrero, M.
 2013
 32 4S p. S208-S209
2 p.
 artikel
28 An Innovative Approach to Selectively Inhibit Mesenchymal Cells Isolated from BOS Patients Cova, E.
 2013
 32 4S p. S82-
1 p.
 artikel
29 An International Survey To Assess Referral Thresholds for Destination Therapy in Non-Inotrope Dependent Patients: Results of the CONSENSUS-DT Study Galvao, M.
 2013
 32 4S p. S131-S132
2 p.
 artikel
30 A Novel Algorithm To Promote Native Aortic Valve Function Using the Next Generation Heartware MVAD Kapur, N.K.
 2013
 32 4S p. S53-S54
2 p.
 artikel
31 A Novel Echocardiographic Measurement in Pediatric Heart Transplant Recipients with Dilated Cardiomyopathy: Can We Maximize the Donor Supply? Hahn, E.
 2013
 32 4S p. S238-S239
2 p.
 artikel
32 A Novel Humanized Model To Study the Development of Obliterative Airway Disease Hua, X.
 2013
 32 4S p. S249-
1 p.
 artikel
33 A Novel Link between G6PD Deficiency and Hemolysis Events in Patients Supported with Continuous-Flow Left Ventricular Assist Devices Alhosaini, H.
 2013
 32 4S p. S38-
1 p.
 artikel
34 A Novel Method of Predicting Aortic Valve Opening through LVAD Power Waveform Analysis Wright, G.A.
 2013
 32 4S p. S223-
1 p.
 artikel
35 A Novel, Risk Stratification Model Using Bayesian Networks for Continuous Flow Left Ventricular Assist Device 90-Day Survival Loghmanpour, N.A.
 2013
 32 4S p. S232-
1 p.
 artikel
36 A Novel Scoring System for Recovery after VAD Implantation in Children: Initial Feasibility Ploutz, M.
 2013
 32 4S p. S289-
1 p.
 artikel
37 Antibodies to Lung Self-Antigens (Ka1 Tubulin or Collagen V) Lead to Epitope Spreading, Loss of Tolerance and Rejection of CTLA4/MR1 Induced Tolerant Murine Lung Allograft Subramanian, V.
 2013
 32 4S p. S77-
1 p.
 artikel
38 Antibody Directed Therapy after Lung Transplant Gray, A.L.
 2013
 32 4S p. S170-S171
2 p.
 artikel
39 Anti-Fibrotic Effect of Combined mTORc1 and mTORc2 Inhibition in Bronchiolitos Obliterans Walker, N.
 2013
 32 4S p. S28-
1 p.
 artikel
40 Anti-Fungal Prophylaxis in Lung Transplant Recipients (LTRs): A Meta-Analysis of Cohort Studies Bhaskaran, A.
 2013
 32 4S p. S130-
1 p.
 artikel
41 Anti-Fungal Prophylaxis in Pediatric Lung Transplantation – An International Multi-Center Survey Mead, L.
 2013
 32 4S p. S291-
1 p.
 artikel
42 Anti-IL6R Attenuates Humoral Responses to Allograft in a Mouse Model of Allosensitization Wu, G.
 2013
 32 4S p. S245-
1 p.
 artikel
43 Aortic Insufficiency and Clinical Outcomes in Patients Undergoing Aortic Valve Procedures at the Time of Continuous Flow Left Ventricular Assist Device Implantation Nahumi, N.
 2013
 32 4S p. S278-
1 p.
 artikel
44 Aortic Valve Commissural Fusion during Continuous-Flow Left Ventricular Assist Device Support Is Associated with Continuous Valve Closure; a Correlation Study between Valve Histopathology and Clinical Patient Characteristics Martina, J.
 2013
 32 4S p. S54-S55
2 p.
 artikel
45 A Phase One, Open Label, Multi-Dose Study To Evaluate the Safety, Tolerability, and Biologic Effects of Three Doses of IW001 in Patients with Idiopathic Pulmonary Fibrosis (IPF) Rothhaar, K.
 2013
 32 4S p. S168-
1 p.
 artikel
46 Apoptosis, Not Necrosis, during Ex-Vivo Lung Perfusion Is Correlated with Severe PGD Hashimoto, K.
 2013
 32 4S p. S41-
1 p.
 artikel
47 Appearance of Posttransplant De Novo Anti-HLA Antibodies in Living-Donor Lobar Lung Transplantation Ohsumi, A.
 2013
 32 4S p. S167-
1 p.
 artikel
48 A Practicable Public Private Partnership Model for Deceased Donor Transplantation – Tamil Nadu Experience Thanikachalam, Mohan
 2013
 32 4S p. S198-S199
2 p.
 artikel
49 A Prospective Pilot-Study of Azithromycin for Lymphocytic Airway Inflammation after Lung Transplantation Vos, R.
 2013
 32 4S p. S88-S89
2 p.
 artikel
50 A Quantitative Assessment of Left Ventricular Assist Device Inflow Cannula Position with Contrast Enhanced Gated Cardiac Multislice Computed Tomography and Its Clinical Correlation Alvarez, P.A.
 2013
 32 4S p. S229-
1 p.
 artikel
51 Are Smaller Children Waiting Longer? Trends in Median Waiting Time for Smaller Children Listed for Heart Transplant in the US Almond, C.S.
 2013
 32 4S p. S35-
1 p.
 artikel
52 Are the Clinical Implications of Lactic Acidosis Similar Post-Cardiac Transplantation Verus Post-LVAD Implantation? Wachter, S.B.
 2013
 32 4S p. S256-S257
2 p.
 artikel
53 Are There Differences in the Development of Proteinuria after Everolimus Initiation and Calcineurin Withdrawal or Not in Heart Transplantation? Paniagua-Martín, M.J.
 2013
 32 4S p. S260-
1 p.
 artikel
54 Artificial Heart Patients Discharged Home with a Portable Pneumatic Driver – The Pivotal US Clinical Trial Experience Kasirajan, V.
 2013
 32 4S p. S149-
1 p.
 artikel
55 A Single Center Transition of Care Model from Pediatric Heart to Adult Services Adams, S.
 2013
 32 4S p. S292-
1 p.
 artikel
56 A Specific Mechanism for Late Loss of Cardiac Allograft: The Antibody Mediated Rejection (AMR) as a Major Factor of Cardiac Allograft Vasculopathy (CAV) Toquet, C.
 2013
 32 4S p. S243-
1 p.
 artikel
57 Assessment of Right Ventricle before the Implantation of Left Ventricular Assist Device by Echocardiographic Parameters (ARVADE) Aissaoui, N.
 2013
 32 4S p. S234-S235
2 p.
 artikel
58 Assessment of Right Ventricular Pressure-Volume Relationships Using 256-Slice CT in an Experimental Model of Acute Pulmonary Hypertension Schmack, B.
 2013
 32 4S p. S301-S302
2 p.
 artikel
59 Assessment of Right Ventricular Systolic Function in Heart Transplant Patients: Correlation between Echocardiography and Cardiac Magnetic Resonance Imaging. Investigation of the Accuracy and Reliability of Echocardiography Simsek, E.
 2013
 32 4S p. S259-
1 p.
 artikel
60 Association of Prior Implantation of HeartMate II Left Ventricular Assistive Device with Post-Heart Transplant Mortality Donneyong, M.M.
 2013
 32 4S p. S32-
1 p.
 artikel
61 ATG Induction Improves Outcome for Sensitized Patients Who Have Undergone Heart Transplantation Phan, A.
 2013
 32 4S p. S200-
1 p.
 artikel
62 Atopy, Eosinophilia, Complete Blood Count (CBC) and the Risk of Rejection in Pediatric Heart Transplant Recipients Arbon, K.
 2013
 32 4S p. S240-
1 p.
 artikel
63 Attenuation of Transplant Arteriosclerosis by Oral Feeding of MHC Encoding Chitosan-DNA Nanoparticles Is Mediated by Humoral Immunity Heim, C.
 2013
 32 4S p. S81-S82
2 p.
 artikel
64 Australia’s Experience with Ex-Vivo Lung Perfusion of Highly Marginal Donors Hopkins, P.M.
 2013
 32 4S p. S154-
1 p.
 artikel
65 Autoantibodies after LVAD: Profiling with Antigen Microarrays Chruscinski, A.
 2013
 32 4S p. S172-S173
2 p.
 artikel
66 Bacteremia after Implantation of Continuous Flow Devices: Associated Factors and Long-Term Outcomes Forest, S.J.
 2013
 32 4S p. S280-
1 p.
 artikel
67 Benefit of Combined Therapy with Nicorandil and Colchicine in Reversing Monocrotaline-Induced Rat Pulmonary Arterial Hypertension Lee, F.-Y.
 2013
 32 4S p. S305-S306
2 p.
 artikel
68 Benefit of Tacrolimus/Myocophenolate To Reduce Cardiac Allograft Vasculopathy after Heart Transplantation Patel, J.
 2013
 32 4S p. S50-
1 p.
 artikel
69 Beyond TICTAC: “Real World” Consecutive Patient Cohort Survival Baran, D.A.
 2013
 32 4S p. S114-
1 p.
 artikel
70 Bi-Caval Dual Lumen Catheter for Veno-Venous Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation for Cystic Fibrosis Nicolas, S.
 2013
 32 4S p. S55-
1 p.
 artikel
71 Biomarkers of Idiopathic Pulmonary Arterial Hypertension (iPAH): Volatile Constituents of Expired Breath Condensates (EBC) as Markers of Disease Severity Using Gas Chromatography/Mass Spectroscopy (GC/MS) Allen, R.P.
 2013
 32 4S p. S62-
1 p.
 artikel
72 Biopsy Proven Liver Fibrosis and Outcomes in Patients Supported with a Continuous-Flow Left Ventricular Assist Device Lee, S.
 2013
 32 4S p. S285-
1 p.
 artikel
73 Blood Group A Transgenic Mice: A Model for ABO-Incompatible (ABOi) Heart Transplantation (HTx) Kratochvil, A.
 2013
 32 4S p. S249-
1 p.
 artikel
74 Blood Pressure Measurement in Patients with Continuous-Flow Left Ventricular Assist Devices Woldendorp, K.D.
 2013
 32 4S p. S91-S92
2 p.
 artikel
75 Body Mass Index Impacts Immediate and Long-Term Survival of Heart Transplant Recipients Ravi, Y.
 2013
 32 4S p. S39-
1 p.
 artikel
76 Bridge-to-Decision LVAD Support Using the Impella 5.0 Via a Right Subclavian Artery Approach Bansal, A.
 2013
 32 4S p. S281-
1 p.
 artikel
77 Bridge to Lung Transplantation with Veno-Venous Extracorporeal Membrane Oxygenation for End-Stage Lung Disease: A Single Center Experience Evans, C.F.
 2013
 32 4S p. S219-
1 p.
 artikel
78 Bridge to Pediatric Heart Transplantation Using Mechanical Circulatory Support: An Analysis \of the UNOS Database Wehman, B.
 2013
 32 4S p. S127-S128
2 p.
 artikel
79 Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome: Do Specific Risk Factors Differ? Verleden, S.E.
 2013
 32 4S p. S60-
1 p.
 artikel
80 Bronchiolitis Obliterans Syndrome-Free Survival after Two Years in Patients with Higher Frequencies of Regulatory T Cells Early after Lung Transplantation Salman, J.
 2013
 32 4S p. S59-S60
2 p.
 artikel
81 Buying Time: The Use of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation in Pediatric Patients Casswell, G.
 2013
 32 4S p. S291-S292
2 p.
 artikel
82 Calcineurin Inhibitor-Free Immunosuppression in Pediatric Heart Transplantation Recipients: Sirolimus as a Primary Immunosuppressive Agent Loar, R.W.
 2013
 32 4S p. S292-
1 p.
 artikel
83 Cancer in the Norwegian HTx Population; Risk Factors, Incidence and Mortality Compared to General Population Gude, E.
 2013
 32 4S p. S253-
1 p.
 artikel
84 Can C1q in Endomyocardial Biopsies (EMB) Predict AMR and Adverse Outcome? Miller, D.V.
 2013
 32 4S p. S72-S73
2 p.
 artikel
85 Candida Bloodstream Infection in Left Ventricular Assist Device Recipients Riaz, T.
 2013
 32 4S p. S284-
1 p.
 artikel
86 Candidates Listed for Both Single and Double Lung Do Not Have Improved Post-Transplant Survival with Double Lung Transplant Shariati, N.
 2013
 32 4S p. S58-S59
2 p.
 artikel
87 Can Late Gadolinium Enhancement Predict Adverse Clinical Events in Pulmonary Arterial Hypertension? Soma, S.R.
 2013
 32 4S p. S107-
1 p.
 artikel
88 Can Plasma NGAL Predict Renal Response to Conversion from Calcineurin Inhbitor- to Everolimus Based Immunosuppression after Cardiac Transplantation? Gustafsson, F.
 2013
 32 4S p. S293-S294
2 p.
 artikel
89 Can the RV Be Prognostic for the Non-Ischemic Cardiomyopathy Patient but Not the Ischemic Cardiomyopathy Patient? A Cardiovascular MRI Study Gill, S.S.
 2013
 32 4S p. S21-
1 p.
 artikel
90 Carbon Monoxide (CO) Inhalation Prolongs Survival of the Fully MHC-Disparate Lung Graft from Brain Death Donors in Miniature Swine Sahara, H.
 2013
 32 4S p. S153-
1 p.
 artikel
91 Cardiac Allograft Vasculopathy after Heart and Heart-Lung Transplantations: Is There Any Protective Role from the Lung? Guihaire, J.
 2013
 32 4S p. S49-S50
2 p.
 artikel
92 Cardiac Allograft Vasculopathy in HIV-Infected Patients Dizon, S.
 2013
 32 4S p. S210-
1 p.
 artikel
93 Cardiac Allograft Vasculopathy Is Less Frequent in Contemporary Heart Transplant Population Wei, J.
 2013
 32 4S p. S209-S210
2 p.
 artikel
94 Cardiac Rehabilitation after Heart Transplantation Reduces Development of Cardiac Allograft Vasculopathy Thottam, M.
 2013
 32 4S p. S80-
1 p.
 artikel
95 Cardiac Re-Transplantation: A 33-Year Single Centre Clinical Experience Barnard, J.
 2013
 32 4S p. S206-S207
2 p.
 artikel
96 Cardiac Surgery Is Successful in Heart Transplant Recipients Holmes, T.R.
 2013
 32 4S p. S258-S259
2 p.
 artikel
97 Cardiac Transplantation Using Hearts from Donation after Circulatory Death (Dcd) Donors – A Viable Source of Organs? Iyer, A.
 2013
 32 4S p. S247-S248
2 p.
 artikel
98 Cardiopulmonary Bypass Is Associated with Pulmonary Artery Endothelial Dysfunction: Therapeutic Potential of Tezosentan Perrault, L.P.
 2013
 32 4S p. S205-
1 p.
 artikel
99 Cardiovascular Events with De Novo Use of Everolimus in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study Potena, L.
 2013
 32 4S p. S26-
1 p.
 artikel
100 Caspase 1: A Novel Serum Marker of Myocardial Remodeling Statz, C.
 2013
 32 4S p. S136-S137
2 p.
 artikel
101 β-Catenin Activation in Bronchiolitis Obliterans Syndrome Linda, B.
 2013
 32 4S p. S28-
1 p.
 artikel
102 Catheter Ablation of Ventricular Arrhythmias in Patients Supported by Left Ventricular Assist Device Garan, A.R.
 2013
 32 4S p. S228-
1 p.
 artikel
103 C4d by Immunofluorescence and Immunohistochemistry in Routine Lung Allograft Biopsies Roden, A.C.
 2013
 32 4S p. S19-S20
2 p.
 artikel
104 C4d Immunostaining Is an Independent Predictor of Graft Dysfunction, Cardiac Allograft Vasculopathy and Death in Heart Transplant Recipients Luk, A.
 2013
 32 4S p. S243-S244
2 p.
 artikel
105 Centers for Disease Control ‘High-Risk’ Donors and Thoracic Organ Transplantation: Expanding the Donor Pool Arnaoutakis, G.J.
 2013
 32 4S p. S123-
1 p.
 artikel
106 Center Volume Impacts Survival in Pediatric Lung Transplantation Khan, M.S.
 2013
 32 4S p. S145-S146
2 p.
 artikel
107 C1-Esterase-Inhibitor Counteracts Severe Primary Graft Dysfunction in Lung Transplantation Sommer, W.
 2013
 32 4S p. S222-
1 p.
 artikel
108 Change in Maximum Intimal Thickness with Everolimus-Based Immunosuppression after Heart Transplantation in Patients at Increased Risk of Cardiac Allograft Vasculopathy Kobashigawa, J.
 2013
 32 4S p. S25-S26
2 p.
 artikel
109 Changes in Circulating Progenitor Cells Are Associated with Functional Capacity in Heart Failure Patients: A Longitudinal Study Alba, A.C.
 2013
 32 4S p. S96-
1 p.
 artikel
110 Changes in Left Ventricular Ejection Fraction Following Implantation of Left Ventricular Assist Device as Destination Therapy Dunlay, S.M.
 2013
 32 4S p. S116-
1 p.
 artikel
111 Changes of Plasma microRNAs in Heart Transplantation Patients Do Not Reflect microRNA Changes in the Cardiac Allograft Vasculopathy Vessel Wall Huibers, M.M.H.
 2013
 32 4S p. S242-
1 p.
 artikel
112 Characteristics and Cost of Treatment of Acute Rejection within 1 Year after Pediatric Heart Transplant: A Multi-Institutional Study Cabrera, A.G.
 2013
 32 4S p. S194-
1 p.
 artikel
113 Characteristics and Outcome of Influenza Infections in Lung Transplant Recipients: A Single Season Cohort Study Schuurmans, M.M.
 2013
 32 4S p. S48-
1 p.
 artikel
114 Characteristics and Survival of Patients with the Total Artificial Heart Implanted for Indications Other Than Biventricular Failure Thanavaro, K.L.
 2013
 32 4S p. S231-
1 p.
 artikel
115 Characteristics of PAH Patients Treated Initially with Parenteral Prostanoids Differ from Those Treated Initially with Oral Therapy Despite Matching for REVEAL Risk Score Frantz, R.P.
 2013
 32 4S p. S65-
1 p.
 artikel
116 Characterization of Decellularized Porcine Hearts as Scaffolds for Tissue-Engineering Methe, K.
 2013
 32 4S p. S70-
1 p.
 artikel
117 Characterization of the Lung Microbiome in Pediatric Lung Transplant Recipients Luna, R.A.
 2013
 32 4S p. S291-
1 p.
 artikel
118 Characterizing the Agonal Phase of the Non-Heart Beating Donor in Canines – Implications for Utilization of DCD Hearts for Transplantation Brant, S.
 2013
 32 4S p. S158-
1 p.
 artikel
119 Chronic Anemia Is Not a Predictor for Poor Outcome after Heart Transplantation Kittleson, M.
 2013
 32 4S p. S254-S255
2 p.
 artikel
120 Chronic Rejection Lesions Are Decreased in IL-17 KO Mice after Orthotopic Lung Transplantation Vaneylen, A.
 2013
 32 4S p. S104-S105
2 p.
 artikel
121 Chronic Renal Failure in Lung Transplant Recipients Is Predicted by Tacrolimus Toxicity Events Fox, B.D.
 2013
 32 4S p. S90-
1 p.
 artikel
122 Chronotropic Incompetence May Impact Exercise Capacity in Patients Supported by Left Ventricular Assist Device Garan, A.R.
 2013
 32 4S p. S93-
1 p.
 artikel
123 Circulating microRNA: Prognostic Biomarker for Pediatric Heart Failure Miyamoto, S.D.
 2013
 32 4S p. S34-S35
2 p.
 artikel
124 Circulating Mitochondrial DNA Is Elevated in Patients with Immediate Primary Graft Dysfunction Ibrahim, M.
 2013
 32 4S p. S33-
1 p.
 artikel
125 CIRCULITE® SYNERGY® System for the Treatment of Intermacs ≥4 Heart Failure Meyns, B.
 2013
 32 4S p. S148-
1 p.
 artikel
126 Clamshell Incision vs. Sternal-Sparing Incision in Lung Transplantation Arndt, G.
 2013
 32 4S p. S265-
1 p.
 artikel
127 Clinical and Echocardiographic Presentation of Rejection Episodes Following Heart Transplantation Sudini, N.L.
 2013
 32 4S p. S254-
1 p.
 artikel
128 Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection Borgese, L.
 2013
 32 4S p. S103-
1 p.
 artikel
129 Clinical and Prognostic Significance of C3d and C4d Positive Immunopathology Pattern Versus C4d Positive Alone Miller, D.V.
 2013
 32 4S p. S20-
1 p.
 artikel
130 Clinical Characteristics and Outcomes in Patients with Mismatched Filling Pressures in Advanced Heart Failure: Looking beyond the JVP Patel, C.
 2013
 32 4S p. S22-S23
2 p.
 artikel
131 Clinical Consequences of Preoperative anti-HLA Antibodies and Panel Reactive Antibodies in Heart Transplantation Gazdic, T.
 2013
 32 4S p. S203-
1 p.
 artikel
132 Clinical Effects of CD34+ Cell Transplantation in Non-Ischemic Dilated Cardiomyopathy Correlate with Myocardial Cell Engraftment Vrtovec, B.
 2013
 32 4S p. S96-
1 p.
 artikel
133 Clinical Outcomes and Activation of Circulating Endothelial Progenitor Cells Following Application of ASD Occluder in Patients with Flow-Induced Pulmonary Hypertension Hsu, C.-H.
 2013
 32 4S p. S304-
1 p.
 artikel
134 Clinical Outcomes for INTERMACS Profile 1 Patient Implanted with the Total Artificial Heart Shah, K.B.
 2013
 32 4S p. S236-
1 p.
 artikel
135 Clinical Outcomes in Elderly Lung Transplant Recipients 70 Years and Older Bruckner, B.A.
 2013
 32 4S p. S266-S267
2 p.
 artikel
136 Clinical Predictors and Outcome Implications of 30-Day Hospital Readmission in Lung Transplant Recipients Osho, A.A.
 2013
 32 4S p. S265-S266
2 p.
 artikel
137 Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation Diamond, J.M.
 2013
 32 4S p. S43-
1 p.
 artikel
138 Clinical Scores and Echocardiography for Right Ventricular Failure Risk Prediction after Implantation of Continuous-Flow Left Ventricular Assist Devices Kalogeropoulos, A.P.
 2013
 32 4S p. S273-
1 p.
 artikel
139 Clinical Significance of a Positive Cross Match in the Setting of Non-Complement Fixing Donor Specific Antibodies in Adult Heart Transplant Recipients Eshelbrenner, C.
 2013
 32 4S p. S203-S204
2 p.
 artikel
140 Clostridium Difficile Infection Increases Mortality Risk in Lung Transplant Recipients Lee, J.T.
 2013
 32 4S p. S48-S49
2 p.
 artikel
141 Comparative Analysis of von Willebrand Disease in Intensive Care Patients before Mechanical Circulatory Support Oezpeker, C.
 2013
 32 4S p. S55-
1 p.
 artikel
142 Comparative Analysis of von Willebrand Disease in Patients with Mechanical Circulatory Pulsatile and Non-Pulsatile Support Oezpeker, C.
 2013
 32 4S p. S71-S72
2 p.
 artikel
143 Comparing Bortezomib to Traditional Therapies for Antibody-Mediated Rejection (AMR): Out with the Old? Khuu, T.
 2013
 32 4S p. S110-
1 p.
 artikel
144 Comparing Survival of HMII Patients with Elevated LDH: Implications for Medical and Surgical Management Ballew, C.C.
 2013
 32 4S p. S38-
1 p.
 artikel
145 Comparison of an Innovative Everolimus-Containing Quadruple Immunosuppressive Regimen Versus a Standard Triple Regimen in Lung Transplant Recipients and Its Impact on Renal Function, Safety and Efficacy: The 4EVERLUNG Study Design Gottlieb, J.
 2013
 32 4S p. S171-S172
2 p.
 artikel
146 Comparison of Costs, Readmissions and Days out of Hospital at One Year between Heart Transplantation and Continuous Flow LVAD Goldstein, D.J.
 2013
 32 4S p. S98-
1 p.
 artikel
147 Comparison of HLA & MICA Allosensitization Patterns among Patients Supported by Ventricular Assist Devices (VAD) and Patients with No Devices Askar, M.
 2013
 32 4S p. S74-
1 p.
 artikel
148 Comparison of Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IVUS) for the Early Diagnosis of Cardiac Allograft Vasculopathy in Heart Transplant Patients Tissot, C.-M.
 2013
 32 4S p. S209-
1 p.
 artikel
149 Comparison of Post Implant Hemodynamics with 2nd Versus 3rd Generation Continuous Flow Left Ventricular Assist Device Spiegelstein, D.
 2013
 32 4S p. S186-
1 p.
 artikel
150 Comparison of Surgical Wound Infection Etiology in Patients Treated with Short-Term Pulsatile Mechanical Circulatory Support, Receiving Heart Transplant, or Undergoing Other Cardiac Surgery Procedure Copik, I.
 2013
 32 4S p. S197-S198
2 p.
 artikel
151 Complications on the Heart Transplant Waiting List Is Common: Reducing Wait List Time for Sensitized Patients May Avoid Complications Morlend, R.
 2013
 32 4S p. S208-
1 p.
 artikel
152 Concomitant Tricuspid Valve Repair in Patients Undergoing LVAD Placement Reduces Incidence of Acute Right Heart Failure Rodriguez, L.E.
 2013
 32 4S p. S55-S56
2 p.
 artikel
153 Congenital Heart Disease, HLA Sensitization, and Heart Transplantation Dodd, D.A.
 2013
 32 4S p. S237-S238
2 p.
 artikel
154 Contemporary Experience with Percutaneous and Surgical Right Ventricular Assist Devices Um, J.
 2013
 32 4S p. S229-S230
2 p.
 artikel
155 Contemporary Outcomes of Lung Transplantation Using Extracorporeal Membrane Oxygenation as Bridge Bermudez, C.A.
 2013
 32 4S p. S266-
1 p.
 artikel
156 Contemporary Prognosis in Moderate to Severe Heart Failure with Reduced EF: Who Should Be Referred for Advanced Therapy? Thorvaldsen, T.
 2013
 32 4S p. S143-S144
2 p.
 artikel
157 Continuous Flow Left Ventricular Assist Device Patients Are Not at Higher Risk of Gastrointestinal Bleeding with More Aggressive Anticoagulation Smith, J.W.
 2013
 32 4S p. S286-
1 p.
 artikel
158 Continuous Flow Left Ventricular Assist Devices Improve Survival in Reactive but Not Fixed Type 2 Pulmonary Hypertension Compared with Medical Therapy Kumarasinghe, G.
 2013
 32 4S p. S232-S233
2 p.
 artikel
159 Continuous-Flow Left Ventricular Assist Device Versus Heart Transplantation: A European Perspective Ammirati, E.
 2013
 32 4S p. S118-S119
2 p.
 artikel
160 Continuous Flow Left Ventricular Devices Significantly Unload the Pulmonary Vasculature Regardless of the Severity of Mitral Regurgitation Prasad, S.M.
 2013
 32 4S p. S287-
1 p.
 artikel
161 Continuous-Flow Ventricular Assist Devices Impact on Failing Heart’s Vasculature Yen, C.-G.
 2013
 32 4S p. S234-
1 p.
 artikel
162 Continuous Monitoring of Right Ventricular Function with a 3-Axis Accelerometer during Left Ventricular Assist Device Implantation Halvorsen, P.S.
 2013
 32 4S p. S161-S162
2 p.
 artikel
163 Coronary Artery Fistulae after Orthotopic Heart Transplantation Are Associated with Decreased Prevalence of Transplant Coronary Artery Disease Wei, J.
 2013
 32 4S p. S210-S211
2 p.
 artikel
164 Coronary Collaterals Predict Improved Survival and Allograft Function in Patients with Coronary Allograft Vasculopathy Lavine, K.J.
 2013
 32 4S p. S27-
1 p.
 artikel
165 Correlates of Long-Term Survival in the TICTAC Trial Baran, D.A.
 2013
 32 4S p. S135-S136
2 p.
 artikel
166 Correlation of B-Type Natriuretic Peptide (BNP) with Echocardiographic and Catheterization Parameters in Pediatric Heart Recipients Haileselassie, B.
 2013
 32 4S p. S241-S242
2 p.
 artikel
167 Cost Comparison of Continuous-Flow Left Ventricular Assist Devices as Destination Therapy in Patients Over/Under Age 70 Koene, R.J.
 2013
 32 4S p. S224-
1 p.
 artikel
168 Cost-Effective Design of Pulmonary Arterial Hypertension Trials To Detect Changes in Right Ventricular Size and Function: 3D Echocardiography Versus Cardiovascular Magnetic Resonance Addetia, K.
 2013
 32 4S p. S66-
1 p.
 artikel
169 Cost-Effectiveness of Ventricular Assist Device Therapy as a Bridge to Transplant in Comparison to Non-Bridged Cardiac Recipients Alba, A.C.
 2013
 32 4S p. S145-
1 p.
 artikel
170 Cost of 1-Year LVAD Destination Therapy in Chronic Heart Failure; a Comparison with Heart Transplantation Meyns, B.
 2013
 32 4S p. S98-S99
2 p.
 artikel
171 Costs of Transplantation across a Positive Crossmatch West, S.C.
 2013
 32 4S p. S241-
1 p.
 artikel
172 CRT before Transplant or VAD? The Role of CRT in Stage D Heart Failure Liu, S.
 2013
 32 4S p. S111-
1 p.
 artikel
173 CT Volumetry Versus Body Plethysmography in Measuring TLC in Lung Transplantation Sastry, P.
 2013
 32 4S p. S220-
1 p.
 artikel
174 Current Status of Donor Echocardiography in UK Dronavalli, V.B.
 2013
 32 4S p. S157-
1 p.
 artikel
175 Cylex Scores May Predict Risk for Infection in the First Year Following Heart Transplantation Kobashigawa, J.
 2013
 32 4S p. S74-
1 p.
 artikel
176 Cytochrome P450 3A5 Genotype Is Associated with Early Post-Operative Tacrolimus Serum Levels in Lung Transplant Patients Flesch, J.D.
 2013
 32 4S p. S169-
1 p.
 artikel
177 Cytomegalovirus Specific Immunity in Paediatric Cardiac Transplantation Jacobsen, M.C.
 2013
 32 4S p. S150-
1 p.
 artikel
178 Decellularizing Human Hearts: Characterizing Native Cardiac Matrix for Clinical Translation Guyette, J.P.
 2013
 32 4S p. S45-
1 p.
 artikel
179 Decreased Coronary Flow Reserve Measured with Doppler Flow Wire Technique Was Associated with Stenotic Myocardial Microvasculopathy in Pediatric Patients after Heart Transplantation Ide, H.
 2013
 32 4S p. S239-
1 p.
 artikel
180 Defects in Free Fatty Acid Oxidation and Glucose Oxidation Coexist in the Failing Heart Sabbah, H.N.
 2013
 32 4S p. S97-
1 p.
 artikel
181 Detection of Cardiac Allograft Vasculopathy with the New Optical Coherence Tomography in Pediatric Heart Transplant Recipients – Initial Experience Schubert, S.
 2013
 32 4S p. S192-S193
2 p.
 artikel
182 Detection of Restored Lung by Novel Radiologic Parameter in Living Lobar Lung Transplant Donors Mizobuchi, T.
 2013
 32 4S p. S216-
1 p.
 artikel
183 Development and Evaluation of a Novel Combined Perfusion Decellularization Heart-Lung Model Weymann, A.
 2013
 32 4S p. S299-
1 p.
 artikel
184 Development of a Novel Tissue-Compatible Apical Inflow Cannula for an Implantable VAD Mizuno, T.
 2013
 32 4S p. S174-
1 p.
 artikel
185 Development of Coronary Atherosclerosis in Older Donor Hearts after Heart Transplantation Haralambiev, L.
 2013
 32 4S p. S157-S158
2 p.
 artikel
186 Development of De Novo Anti-HLA Antibodies in Pediatric Heart Transplant Recipients Chen, C.K.
 2013
 32 4S p. S193-
1 p.
 artikel
187 Development of 3-Dimensional Prevascularized Scaffold-Free Contractile Cardiac Patch for Heart Regeneration Noguchi, R.
 2013
 32 4S p. S46-
1 p.
 artikel
188 Device Thrombogenicity Emulation: A Novel Methodology To Predict “Hot Spot” Sites of Thrombus Formation in Continuous Flow VADs Slepian, M.J.
 2013
 32 4S p. S180-
1 p.
 artikel
189 Diabetes Dramatically Decreases Survival in Lung Transplant Recipients Hackman, K.L.
 2013
 32 4S p. S214-
1 p.
 artikel
190 Diagnosis of Restrictive Allograft Syndrome (RAS) without Using Total Lung Capacity Sato, M.
 2013
 32 4S p. S105-
1 p.
 artikel
191 Differences in Exercise Capacity among Left Ventricular Assist Device Recipients Correlate More with Resting Filling Pressures Than Systolic Function Vader, J.
 2013
 32 4S p. S92-S93
2 p.
 artikel
192 Differential Impacts of Implantable Ventricular Assist Device on Quality of Life and Depression in Patients with Heart Failure and Their Caregivers Kato, N.
 2013
 32 4S p. S127-
1 p.
 artikel
193 Differential Response to Afterload in Axial and Centrifugal Continuous Flow Left Ventricular Assist Devices (CV-LVAD) Lampert, B.C.
 2013
 32 4S p. S57-
1 p.
 artikel
194 Different Impact on the Coagulation System of Two Continuous Flow LVADs: Axial Versus Centrifugal Flow Tarzia, V.
 2013
 32 4S p. S177-
1 p.
 artikel
195 Diffuse Alveolar Damage as an Isolated Finding after Lung Transplantation: Beneficial Effect of Corticotherapy Stephan, F.
 2013
 32 4S p. S269-
1 p.
 artikel
196 Discovery of mRNA Biomarkers Predicting Donor Lung Failure Zamel, R.
 2013
 32 4S p. S45-S46
2 p.
 artikel
197 Disparities in Lung Transplantation before and after Introduction of the Lung Allocation Score Wille, K.M.
 2013
 32 4S p. S58-
1 p.
 artikel
198 Distinct Lymphocyte Subsets Infiltrate the Small and Large Airway Epithelium after Lung Transplantation Yerkovich, S.T.
 2013
 32 4S p. S75-S76
2 p.
 artikel
199 Do Donor Characteristics Matter? Prediction of Graft Utilization and Recipient Outcomes after Heart Transplantation Khush, K.K.
 2013
 32 4S p. S93-S94
2 p.
 artikel
200 Does Acuity of Presentation Impact the Incidence of Right Ventricular Failure Following Left Ventricular Assist Device Implantation? Kalavrouziotis, D.
 2013
 32 4S p. S230-
1 p.
 artikel
201 Does Age Matter? Immunogenic and Biologic Differences between Young and Old Mesenchymal Stromal Cells Stubbendorff, M.
 2013
 32 4S p. S299-S300
2 p.
 artikel
202 Does Cardiopulmonary Arrest and Resuscitation of Heart Donors Portend Inferior Outcomes in Heart Transplantation Recipients? Quader, M.A.
 2013
 32 4S p. S94-
1 p.
 artikel
203 Does CMV Mismatch Status Modify the Risk of PTLD Due to EBV Mismatch Status in Lung and Heart Transplant Recipients? Luong, M.-L.
 2013
 32 4S p. S130-
1 p.
 artikel
204 Does Educational Level and Insurance Impact Mid-Term Survival after Left Ventricular Assist Device Implantation? Combs, P.S.
 2013
 32 4S p. S124-S125
2 p.
 artikel
205 Does Gender Influence Survival of Heart Transplant (HT) Recipients Bridged with LVAD Support? DePasquale, E.C.
 2013
 32 4S p. S173-S174
2 p.
 artikel
206 Does Mechanical Circulatory Support Prior to Heart Transplantation Influence Early Onset of Coronary Allograft Vasculopathy Welp, H.A.
 2013
 32 4S p. S210-
1 p.
 artikel
207 Does Red Blood Cell Fragility Predict the Degree of Post-LVAD Hemolysis? Madden, J.L.
 2013
 32 4S p. S273-
1 p.
 artikel
208 Does Regular Exercise after Heart Transplantation Have Any Benefit? Real Life Experience Daun, T.
 2013
 32 4S p. S198-
1 p.
 artikel
209 Does Surgeon Training or Hospital (Pediatric vs. Adult) Affect Survival after Heart Transplant in Adults with Congenital Heart Disease? Boucek, D.
 2013
 32 4S p. S240-S241
2 p.
 artikel
210 Donation after Circulatory Death Lung Activity in the UK – 100 Transplants and Counting Thomas, H.L.
 2013
 32 4S p. S15-
1 p.
 artikel
211 Donor Alcohol Abuse Increases the Risk for Graft Dysfunction in Lung Transplant Recipients Lowery, E.M.
 2013
 32 4S p. S58-
1 p.
 artikel
212 Donor Hearts Not Offered or Rejected for Transplantation – A Lost Opportunity? DiMaio, J.M.
 2013
 32 4S p. S156-
1 p.
 artikel
213 Donor Pulmonary Status Impacts Survival in Cardiac Transplant Recipients Madden, J.L.
 2013
 32 4S p. S94-
1 p.
 artikel
214 Donor-Recipient Size Matching in Pediatric Heart Transplantation: Is Weight the Most Appropriate Parameter To Predict Outcomes in All Age Groups? Bayoumi, A.S.
 2013
 32 4S p. S128-S129
2 p.
 artikel
215 Donor-Recipient Size Mismatch in Lung Transplantation Does Not Negatively Impact Survival: An Review of the UNOS Database Bittle, G.J.
 2013
 32 4S p. S122-S123
2 p.
 artikel
216 Do Racial and Sex Disparities Exist in Clinical Characteristics and Outcomes for Patients Undergoing Left Ventricular Assist Device Implantation? Stulak, J.M.
 2013
 32 4S p. S279-S280
2 p.
 artikel
217 Driveline Exit Site in Long Term LVAD’s – Patient Choice or Surgeon’s Decision Wrightson, N.
 2013
 32 4S p. S80-
1 p.
 artikel
218 Driveline Infections and Sepsis in Patients Receiving the HVAD System as a Left-Ventricular Assist Device John, R.
 2013
 32 4S p. S83-
1 p.
 artikel
219 Driveline Infections in a Large Cohort of Continuous Flow Left Ventricular Assist Device (LVAD) Recipients: The Impact of Pseudomonas on Deep Driveline Involvement Koval, C.E.
 2013
 32 4S p. S83-S84
2 p.
 artikel
220 Durability of DeVega Tricuspid Valve Annuloplasty for Severe Tricuspid Regurgitation at the Time of Continuous-Flow LVAD Implantation Akhter, S.A.
 2013
 32 4S p. S226-
1 p.
 artikel
221 Dynamic BMI Changes in Patients Implanted with Continuous Flow Left Ventricular Assist Devices: Evidence for Reversibility of Cardiac Cachexia and Impact on Survival Kobrin, D.M.
 2013
 32 4S p. S90-S91
2 p.
 artikel
222 Dynamic Changes in Dominant Antigen Responses Following Primary CMV Infection in Lung Transplant Recipients Pipeling, M.R.
 2013
 32 4S p. S298-
1 p.
 artikel
223 Dynamics of Galectin-3 Levels Following Left Ventricular Assist Device Implantation Coromilas, E.J.
 2013
 32 4S p. S115-S116
2 p.
 artikel
224 Early Bacterial Bronchopulmonary Infection after Lung Transplantation: Bacterial Epidemiology and Diagnostic Value of Clinical and Biological Parameters Desmard, M.
 2013
 32 4S p. S189-
1 p.
 artikel
225 Early Echocardiographic Predictors of Alveolar Capillary Dysplasia: A Case-Control Study Arcinue, R.
 2013
 32 4S p. S291-
1 p.
 artikel
226 Early Elevation in Pump Power with the HeartMate II Left Ventricular Assist Device Does Not Predict Late Adverse Events Salerno, C.
 2013
 32 4S p. S38-S39
2 p.
 artikel
227 Early Extubation in Operating Room after Heart Transplantation Poptsov, V.N.
 2013
 32 4S p. S261-S262
2 p.
 artikel
228 Early Fungal Bronchial Colonization after Lung Transplantation: Risk Factors and Outcome Tanaka, S.
 2013
 32 4S p. S189-S190
2 p.
 artikel
229 Early Inflammatory Predictors of Cardiac Allograft Vasculopathy Labarrere, C.A.
 2013
 32 4S p. S51-
1 p.
 artikel
230 Early Inflammatory Predictors of Post-Transplant Major Adverse Cardiac Events Labarrere, C.A.
 2013
 32 4S p. S255-
1 p.
 artikel
231 Early Mortality and Morbidity in First 60 Days in Adult Heart Transplant Recipients with Prior History of Cardiac Surgery: Analysis of United Network for Organ Sharing Database Kansara, P.
 2013
 32 4S p. S162-
1 p.
 artikel
232 Echocardiographic Parameters Associated with Clinical Heart Failure Due to Partial Left Ventricular Unloading in Patients with Continuous-Flow LVAD Vivo, R.P.
 2013
 32 4S p. S277-
1 p.
 artikel
233 ECMO as a Bridge to Decision in “Crash an Burn” Patients: 8-Years Experience Juthier, F.
 2013
 32 4S p. S182-
1 p.
 artikel
234 ECMO at Heart Transplant Listing: Has Waitlist Survival Improved in the Era of Pediatric VAD Support? Almond, C.S.
 2013
 32 4S p. S35-S36
2 p.
 artikel
235 Effect of Blood Pressure (BP) Control in Continuous Flow Left Ventricular Assist Devices (CF-LVAD) on Aortic Insufficiency (AI) and Neurologic Events Lampert, B.C.
 2013
 32 4S p. S30-S31
2 p.
 artikel
236 Effect of Body Position on Continuous Flow Left Ventricular Assist Device Flow Dynamics Muthiah, K.
 2013
 32 4S p. S233-
1 p.
 artikel
237 Effect of Continuous-Flow Mechanical Support on Microvasculature Remodeling in the Failing Heart Saito, T.
 2013
 32 4S p. S32-
1 p.
 artikel
238 Effect of Ex-Vivo Lung Perfusion (EVLP) on Metabolomic Profile of Human Lungs Egan, T.
 2013
 32 4S p. S247-
1 p.
 artikel
239 Effect of Initial Surgical Palliation on HLA Sensitization and Outcomes in Children Transplanted for Hypoplastic Left Heart Syndrome (HLHS) Ideen, C.
 2013
 32 4S p. S238-
1 p.
 artikel
240 Effect of Perioperative Renal Replacement Therapy on Mechanical Circulatory Support Outcomes Bowdish, M.E.
 2013
 32 4S p. S132-S133
2 p.
 artikel
241 Effect of Symptom Clusters on Quality of Life in Patients with Heart Failure Salyer, J.
 2013
 32 4S p. S126-S127
2 p.
 artikel
242 Effect of Therapeutic Drug Monitoring (TDM) on the Efficacy and Safety of Pre-Emptive Voriconazole in Lung Transplant Recipients Morrissey, O.
 2013
 32 4S p. S189-
1 p.
 artikel
243 Effect of VAD Use on HLA Sensitization and Risk of Rejection Post-Heart Transplant in US Children with Dilated Cardiomyopathy Almond, C.S.
 2013
 32 4S p. S108-
1 p.
 artikel
244 Effect of Warm Perfusion of Donor Lungs Using the OCS on Immune Mediator Release during Preservation Wiegmann, B.
 2013
 32 4S p. S153-S154
2 p.
 artikel
245 Effects of Anti-HLA Antibodies Present before Heart Transplantation on Survival, Acute Cellular Rejection and Coronary Allograft Vasculopathy: A Single Center Experience Eschborn, J.M.
 2013
 32 4S p. S261-
1 p.
 artikel
246 Effects of Hyperglycemia on Primary Graft Dysfunction in Lung Transplantation Weir, W.
 2013
 32 4S p. S271-
1 p.
 artikel
247 Effects of Parenteral Treprostinil on Functional Capacity, Hemodynamics, and Right Heart Function in Patients Referred to LTx with Pulmonary Fibrosis & Significant PH Saggar, R.
 2013
 32 4S p. S106-
1 p.
 artikel
248 Efficacy of BAL Galactomannan (GM) and Culture Based Pre-Emptive Antifungal Therapy (PET) in Lung Transplant Recipients (LTRs) Bhaskaran, A.
 2013
 32 4S p. S49-
1 p.
 artikel
249 Elevated Levels of Inflammation in Patients on Long-Term Continuous Flow Left Ventricular Assist Device (CF-LVAD) Support Grosman-Rimon, L.
 2013
 32 4S p. S275-S276
2 p.
 artikel
250 Elevated Pre-Transplant Pulmonary Vascular Resistance Is Not Associated with Mortality in Children without Congenital Heart Disease: A Multi-Center Study Richmond, M.E.
 2013
 32 4S p. S35-
1 p.
 artikel
251 Eligibility and Availability of Lungs for Transplantation: The French Experience Lamy, F.X.
 2013
 32 4S p. S154-
1 p.
 artikel
252 End of an Era: Reduced Severity of Tricuspid Regurgitation in Cardiac Transplant Recipients Managed with Molecular Diagnostic Testing Feitell, S.
 2013
 32 4S p. S255-
1 p.
 artikel
253 Endothelial Activation and Coagulation Homeostasis Play a Role in Coronary Allograft Vasculopathy after Heart Transplantation in Children Fenton, M.
 2013
 32 4S p. S128-
1 p.
 artikel
254 Endothelin-1 and Big-Endothelin-1 as Potential Biomarkers in Clinical Ex Vivo Lung Perfusion Machuca, T.N.
 2013
 32 4S p. S67-
1 p.
 artikel
255 Endothelin Receptor Blocker Medication during Mechanical Circulatory Support Does Not Influence Myocardial Fibrosis in Ventricular Assist Device Patients Milting, H.
 2013
 32 4S p. S110-
1 p.
 artikel
256 Endovascular Application of the CircuLite® Synergy® Circulatory Support System Kar, S.
 2013
 32 4S p. S228-S229
2 p.
 artikel
257 End Stage Heart Failure: Cardiologists’ Reluctance To Discuss End of Life Care Karlekar, M.B.
 2013
 32 4S p. S160-S161
2 p.
 artikel
258 Enhanced Ca2+ Influx through Cardiac L-Type Ca2+ Channels Maintains the Systolic Ca2+ Transient in Cardiac Unloading Schwoerer, A.P.
 2013
 32 4S p. S230-
1 p.
 artikel
259 Eosinophilia Associated Chronic Lung Allograft Dysfunction: A New Phenotype? Piégay, F.
 2013
 32 4S p. S221-
1 p.
 artikel
260 Epigenetic Analysis of the TSDR of FOXP3 Demonstrates That Natural Treg Infiltrate the Cardiac Allograft Already before an Acute Rejection Episode Boer, K.
 2013
 32 4S p. S102-
1 p.
 artikel
261 Epitifibatide in the Treatment of Continuous Flow Left Ventricular Assist Device Thrombosis: A Case Series Bradbury, M.M.
 2013
 32 4S p. S294-
1 p.
 artikel
262 Establishing a PRA Threshold To Treat Sensitized Patients Awaiting Heart Transplant in the Era of the Virtual Crossmatch Kobashigawa, J.
 2013
 32 4S p. S53-
1 p.
 artikel
263 Estimation of Minimal Important Differences in Health-Related Quality of Life Measures for Lung Transplant Recipients Singer, L.G.
 2013
 32 4S p. S214-S215
2 p.
 artikel
264 Evaluation of End Stage Heart Failure Patients on Inotropic Therapy in the Defibrillator Era Caccamo, M.
 2013
 32 4S p. S162-
1 p.
 artikel
265 Evaluation of Left Ventricular Assist Device Inflow Cannula Contact with Ventricular Wall on Cardiac CT Abramov, D.
 2013
 32 4S p. S281-
1 p.
 artikel
266 Evaluation of the DuraHeart® Left Ventricular Assist Device for the Treatment of Advanced Heart Failure in Patients Awaiting Heart Transplantation Feldman, D.
 2013
 32 4S p. S185-S186
2 p.
 artikel
267 Evaluation of the Infant Jarvik Ventricular Assist Device in a Chronic Juvenile Sheep Model Watkins, A.C.
 2013
 32 4S p. S108-S109
2 p.
 artikel
268 Even Mild Renal Insufficiency Is a Risk for Mortality after Heart Transplant Kittleson, M.
 2013
 32 4S p. S40-
1 p.
 artikel
269 Everolimus-Based Immunosuppression Improves Renal Function in Long-Term Heart Transplanted Patients: Five Years Results of a Prospective Randomized Trial Fiocchi, R.
 2013
 32 4S p. S135-
1 p.
 artikel
270 Exhausted T Helper Cells in Lung Transplantation Portend Worse Outcome Chao, F.-Y.
 2013
 32 4S p. S61-
1 p.
 artikel
271 Exploring Palliative Planning for Device Patients: A Need for Patient Defined Criteria for Discontinuation of Support Knapstein, A.M.
 2013
 32 4S p. S125-S126
2 p.
 artikel
272 Exploring Parenthood in the New Zealand Heart Transplant Program Wasywich, C.
 2013
 32 4S p. S213-
1 p.
 artikel
273 Expression of Cardiolipin Biosynthesis and Remodeling Enzymes in Adult Heart Failure Grudis, J.E.
 2013
 32 4S p. S97-S98
2 p.
 artikel
274 Extended Criteria Donors; a Safe Way To Expand the Lung Donor Pool? Somers, J.
 2013
 32 4S p. S155-
1 p.
 artikel
275 Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation: Long-Term Follow-Up Dellgren, G.
 2013
 32 4S p. S218-S219
2 p.
 artikel
276 Extra-Corporeal Membrane Oxygenation Support in Cardiac Transplantation Bittner, H.B.
 2013
 32 4S p. S257-
1 p.
 artikel
277 Extracorporeal Membrane Oxygenation Support System as Bridge to Solution in Refractory Cardiogenic Shock Loforte, A.
 2013
 32 4S p. S186-
1 p.
 artikel
278 Extracorporeal Photopheresis in Pediatric Heart Transplantation Carlo, W.F.
 2013
 32 4S p. S194-
1 p.
 artikel
279 Ex Vivo Heart Preservation: Impact of an Acellular Hemoglobin-Based Oxygen Carrier on Myocardial Function and Energy Metabolism White, C.W.
 2013
 32 4S p. S95-
1 p.
 artikel
280 Ex Vivo Intracoronary Gene Transfer of Adeno Associated Virus Serotype 2 Is Superior to Serotypes 8 and 9 in Transfecting Heart Transplants in the Rat Raissadati, A.
 2013
 32 4S p. S250-S251
2 p.
 artikel
281 Ex Vivo Lung Perfusion of Rejected Human Donor Lungs; Are Donor Lungs with Prolonged Cold Ischemic Time Re-Conditioned by EVLP? Okamoto, T.
 2013
 32 4S p. S67-
1 p.
 artikel
282 Ex-Vivo Perfusion of Human Donor Hearts Reduces Cold Ischemia Time Deng, M.
 2013
 32 4S p. S156-
1 p.
 artikel
283 Factors Modifying Risk of Bleeding in Patients with Continuous Flow Left Ventricular Assist Devices Tricarico, N.
 2013
 32 4S p. S278-S279
2 p.
 artikel
284 Failed Prednisone Taper off after Heart Transplant: Is There a Price To Be Paid? Kittleson, M.
 2013
 32 4S p. S200-
1 p.
 artikel
285 Favorable Outcomes of Donation after Cardiac Death in Lung Transplantation: A Multicenter Study Cypel, M.
 2013
 32 4S p. S15-
1 p.
 artikel
286 Favorable Outcomes Using Long-Term Implantable Left Ventricular Assist Devices in Patients Sixty Five Years of Age and Older Morgan, J.A.
 2013
 32 4S p. S277-S278
2 p.
 artikel
287 Fibrin on Endomyocardial Biopsy: A Significant Predictor of Cardiovascular Mortality beyond pAMR Score Budge, D.
 2013
 32 4S p. S100-S101
2 p.
 artikel
288 Fibroblast Growth Factor 23 Is a Promissing Marker of Myocardial Pathology Polyakova, V.
 2013
 32 4S p. S243-
1 p.
 artikel
289 Fifteen Year Experience of Bridging to Heart Transplantation with Ventricular Assist Devices Berman, M.
 2013
 32 4S p. S225-S226
2 p.
 artikel
290 First-in-Man Transfemoral Transcatheter Aortic Valve Implantation for Severe Aortic Regurgitation in a Patient with Left Ventricular Assist Device Lavee, J.
 2013
 32 4S p. S187-S188
2 p.
 artikel
291 Fluid Challenge To Identify Pulmonary Venous Hypertension Robbins, I.M.
 2013
 32 4S p. S63-
1 p.
 artikel
292 Frailty and Early Mortality after Lung Transplantation: Preliminary Results Lederer, D.J.
 2013
 32 4S p. S119-S120
2 p.
 artikel
293 Frailty Index Predicts Mortality but Not Rehospitalization after Destination Left Ventricular Assist Device Dunlay, S.M.
 2013
 32 4S p. S140-
1 p.
 artikel
294 Frailty Is Common in Lung Transplant Candidates and Associated with Poorer Health-Related Quality of Life Singer, J.P.
 2013
 32 4S p. S43-
1 p.
 artikel
295 Functional and Quality of Life Improvements in Treated Patients with Chronic Thromboembolic Pulmonary Hypertension Thakrar, M.V.
 2013
 32 4S p. S304-
1 p.
 artikel
296 Functional Association between a Genetic Variant in the IL-17 Receptor Gene and Chronic Rejection after Lung Transplantation Ruttens, D.
 2013
 32 4S p. S33-
1 p.
 artikel
297 Gastrointestinal Bleeding Was Rare with Centrifugal Type Continuous Flow Left Ventricular Assist Device EVAHEART Ichihara, Y.
 2013
 32 4S p. S233-S234
2 p.
 artikel
298 Gastroparesis after Lung Transplantation: Prevalence, Reversibility and Relation with Outcome Smit, J.
 2013
 32 4S p. S264-
1 p.
 artikel
299 Gender Differences in Health-Related Quality of Life and Adherence 5 Years after Heart Transplantation Grady, K.L.
 2013
 32 4S p. S196-S197
2 p.
 artikel
300 Gender Differences in Response to PAH Therapy: 6MWD and Time to Clinical Worsening Rusiecki, J.
 2013
 32 4S p. S252-
1 p.
 artikel
301 Gene Expression Profiling in Pediatric Heart Transplant Rejection Knecht, K.R.
 2013
 32 4S p. S287-S288
2 p.
 artikel
302 Gene Expression Profiling To Predict the Development of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients Xu, Z.
 2013
 32 4S p. S60-S61
2 p.
 artikel
303 Gene Set Enrichment Analysis of Bronchial Alveolar Lavage Fluid Identifies Key Innate Immune Pathways in Primary Graft Dysfunction after Lung Transplantation Cantu, E.
 2013
 32 4S p. S41-S42
2 p.
 artikel
304 Genomics of Myocardial Recovery in Patients with Mechanical Circulatory Support Milting, H.
 2013
 32 4S p. S229-
1 p.
 artikel
305 Growth Differentiation Factor 15 (GDF-15) Is Related to Anemia and Iron Metabolism in Heart Allograft Recipients Przybylowski, P.
 2013
 32 4S p. S259-S260
2 p.
 artikel
306 HAS-BLED and CHA2DS2-VASc Scores as Predictors of Bleeding and Thrombotic Risk after HeartMate II Ventricular Assist Device Implantation Koene, R.J.
 2013
 32 4S p. S71-
1 p.
 artikel
307 Has the Incidence of Pump Thrombosis and Stroke in Patients with a HeartMate II Increased over Time? Nagpal, A.D.
 2013
 32 4S p. S29-S30
2 p.
 artikel
308 Health-Related Quality of Life among Patients with Mechanical Circulatory Assistance: Clinician Perspectives Grady, K.L.
 2013
 32 4S p. S196-
1 p.
 artikel
309 Health Status and Emotional Distress in Patients with a Left Ventricular Assist Device and Their Partners: A Comparative Study Brouwers, C.
 2013
 32 4S p. S125-
1 p.
 artikel
310 Health Status, Anxiety and Depression in Heart Failure Patients after Heart Transplantation Versus Left Ventricular Assist Device Implantation Brouwers, C.
 2013
 32 4S p. S195-S196
2 p.
 artikel
311 HeartMate II Device Exchange: Single Center Experience Ota, T.
 2013
 32 4S p. S56-S57
2 p.
 artikel
312 HeartMate II Explants Due to Hemolysis Show Acute on Chronic Laminar Fibrin Layering at Stators Prasad, S.M.
 2013
 32 4S p. S37-S38
2 p.
 artikel
313 Heartmate II Inflow Cannula Position on Chest X-Ray Predicts Inotrope Dependence Sell, K.A.
 2013
 32 4S p. S176-
1 p.
 artikel
314 Hearts from Donations after Circulatory Death (DCD) Donors – Assessment in a Porcine Transplant Model Utilising Transmedics Organ Care System for Organ Perfusion Preservation Iyer, A.
 2013
 32 4S p. S68-S69
2 p.
 artikel
315 Heart Transplant: A Mystery in the Myocardium Cotarlan, V.
 2013
 32 4S p. S138-
1 p.
 artikel
316 Heart Transplant Recipients with LVADs and Pulmonary Hypertension Do Not Benefit from “Oversized” Donor Hearts Whitson, B.A.
 2013
 32 4S p. S14-
1 p.
 artikel
317 Heart Transplant Workup Medical Imaging and Resulting Radiation Exposure McKenzie, S.C.
 2013
 32 4S p. S206-
1 p.
 artikel
318 Hemocompatibility of a Fully Magnetically Levitated Centrifugal LVAD: Results from the DuraHeart Pivotal Trial Moazami, N.
 2013
 32 4S p. S11-
1 p.
 artikel
319 Hemodynamic Assessment in Patients on Chronic Continuous Flow Left Ventricular Assist Device Support Hasin, T.
 2013
 32 4S p. S224-
1 p.
 artikel
320 Hemodynamic Benefits of Chronic Sildenafil Therapy in Advanced Heart Failure (HF): A Multi-Center Experience Sassier, J.
 2013
 32 4S p. S22-
1 p.
 artikel
321 Hemodynamic Changes after Surgical MAZE: Pulmonary Hypertension Secondary to Stiff Left Atrial Syndrome? Fenstad, E.R.
 2013
 32 4S p. S62-
1 p.
 artikel
322 Hemodynamic Evaluation of HeartWare MVAD in Normal and Infarct Swine Models Pham, D.T.
 2013
 32 4S p. S184-S185
2 p.
 artikel
323 Hemolysis and Pump Thrombus in Continuous Flow Left Ventricular Assist Device Recipients Does Not Affect Survival Whitson, B.A.
 2013
 32 4S p. S223-S224
2 p.
 artikel
324 Hemolysis in Patients Supported with Durable, Long-Term Left Ventricular Assist Device Therapy Katz, J.N.
 2013
 32 4S p. S37-
1 p.
 artikel
325 Hemolysis Is Strongly Associated with Mortality in LVAD Patients Ravichandran, A.
 2013
 32 4S p. S56-
1 p.
 artikel
326 Hepatic Dysfunction in Ambulatory Patients with Heart Failure – Application of the MELD Scoring System for Outcome Prediction Kato, T.S.
 2013
 32 4S p. S165-
1 p.
 artikel
327 Higher Donor Body Mass Index Is Associated with Higher Risk of Cardiac Allograft Vasculopathy Khalife, W.I.
 2013
 32 4S p. S211-
1 p.
 artikel
328 High Intensity Interval Training Reduces Progression of Cardiac Allograft Vasculopathy among Heart Transplant Recipients – Results from a Randomized Controlled Trial Nytrøen, K.
 2013
 32 4S p. S27-
1 p.
 artikel
329 High Rate of Reactivation of Chagas Disease after Heart Transplantation in the United States Kransdorf, E.
 2013
 32 4S p. S130-
1 p.
 artikel
330 Histological Characterization of Pulmonary Transplant Patients with Donor Specific Antibodies and Those without Xu, L.
 2013
 32 4S p. S19-
1 p.
 artikel
331 Histological Findings of Bronchial Biopsies and De Novo Donor Specific HLA Antibodies: Comparing Notes Askar, M.
 2013
 32 4S p. S169-
1 p.
 artikel
332 Histomorphometric Analysis of Myocardial Fibrosis after Heart Transplantation Kretschmer, S.
 2013
 32 4S p. S263-
1 p.
 artikel
333 Histopathologic Features of Explanted Lungs Supported by Veno-Venous Extracorporeal Membrane Oxygenation Evans, C.F.
 2013
 32 4S p. S244-
1 p.
 artikel
334 Hit the Road: A Multicenter Evaluation of Driving with LVADs Emani, S.
 2013
 32 4S p. S98-
1 p.
 artikel
335 HLA Allosensitization in ECMO as a Bridge to Lung Transplantation Zeltzer, S.
 2013
 32 4S p. S170-
1 p.
 artikel
336 HLA Antibodies after Lung Transplantation: Early Results of the HALT Study Hachem, R.R.
 2013
 32 4S p. S76-S77
2 p.
 artikel
337 Home Discharge and Out-of-Hospital Follow-Up of Total Artificial Heart Patients Supported by a Portable Driver El Banayosy, A.
 2013
 32 4S p. S285-S286
2 p.
 artikel
338 Home INR Monitoring: Does It Help Reduce the Chance of Re-Admission for LVAD Patients? Han, J.
 2013
 32 4S p. S179-
1 p.
 artikel
339 Hospital Charges, Length of Stay, and Outcomes of Hospital Readmissions in the First Two Years after Pediatric Heart Transplantation McCandless, K.V.
 2013
 32 4S p. S129-
1 p.
 artikel
340 Hospital Readmission in Left Ventricular Assist Device (LVAD) Patients Compared to Patients Receiving Intravenous Inotropic Therapy Whittier, J.
 2013
 32 4S p. S24-
1 p.
 artikel
341 Hospital Readmissions in Left Ventricular Assist Device (LVAD) Recipients: Analysis of Bridge to Transplant (BTT) and Destination Therapy (DT) Bradner, M.
 2013
 32 4S p. S99-
1 p.
 artikel
342 Human EPCR Expression in GalTKO.hCD46 Lungs Extends Survival Time and Lowers PVR in a Xenogenic Lung Perfusion Model Budorf, L.
 2013
 32 4S p. S137-
1 p.
 artikel
343 Human Leukocyte Antigen-G Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation Mociornita, A.G.
 2013
 32 4S p. S298-
1 p.
 artikel
344 Human Leukocyte Antigen-G Inhibits Neutrophil Adhesion to Coronary Artery Endothelial Cells Injured by Tumor Necrosis Factor Alpha Mociornita, A.G.
 2013
 32 4S p. S300-
1 p.
 artikel
345 Human Leukocyte Antigen Mismatch in Heart Transplants Continues To Predict Outcomes in Modern Era of Immunosuppression Carvajal, T.
 2013
 32 4S p. S213-
1 p.
 artikel
346 Human Platelet Aggregation and Thrombotic Microangiopathy (TM) in Pig Cardiac Xenografts Is Reduced by Expression of Human Thrombomodulin (TBM) Iwase, H.
 2013
 32 4S p. S137-
1 p.
 artikel
347 Hybrid ECMO Using AvalonElite DLC for Circulatory Support Guarantees Adequate Heart/Brain Oxygen Supply Zhao, J.
 2013
 32 4S p. S117-S118
2 p.
 artikel
348 Hydrogen Inhalation during Ex Vivo Lung Perfusion Ameliorates the Quality of Lung Grafts in Rats Noda, K.
 2013
 32 4S p. S66-S67
2 p.
 artikel
349 Hypogammaglobulinaemia Post-Lung Transplant Is Associated with Deficient B Cell Function Yerkovich, S.T.
 2013
 32 4S p. S271-
1 p.
 artikel
350 Hypoxia Inducible Factor 1α-Driven Vascular Endothelial Growth Factor and Stromal Derived Factor-1 Signaling Are Maintained in the Hypertrophied Right Ventricle in Congenital Heart Disease: Implications for Pulmonary Hypertension Dromparis, P.
 2013
 32 4S p. S105-S106
2 p.
 artikel
351 Hypoxia-Inducible Transcription Factor Target Genes VEGF and TGF-β Modulate Transplant Arteriosclerosis in a Murine Aortic Allograft Model Heim, C.
 2013
 32 4S p. S250-
1 p.
 artikel
352 Identical Biofilm Forming Strains of Pseudomonas aeruginosa Occur in Lung Allograft BAL and Gastric Juice from CF Patients with Gastro Oesophageal Reflux Krishnan, A.
 2013
 32 4S p. S28-
1 p.
 artikel
353 IgG Immunologic Monitoring To Identify Lung Recipients at Risk of Oportunistic Infections: Prospective Multicenter Study Sarmiento, E.
 2013
 32 4S p. S168-
1 p.
 artikel
354 IL-17 Regulate the Polarization of Macrophages To Promote the Development of Obliterative Bronchiolitis in Murine Trachea Transplantation Model Zhou, X.
 2013
 32 4S p. S297-
1 p.
 artikel
355 Immediate Post-Operative Bronchoalveolar IL-6 and IL-8 Cytokine Levels Are Associated with Short-Term Patient Outcome and Long-Term Allograft Outcome after Lung Transplantation Vos, R.
 2013
 32 4S p. S29-
1 p.
 artikel
356 Immunohistochemical Counting of Mononuclear Infiltrates in Endomyocardial Biopsy Fragments: A New Method To Improve the Diagnosis of Rejection after Heart Transplantation Bocchi, E.A.
 2013
 32 4S p. S74-S75
2 p.
 artikel
357 Impact of Adolescent Age on Graft Survival in Patients with Congenital Heart Disease Versus Myocarditis Savla, J.J.
 2013
 32 4S p. S191-
1 p.
 artikel
358 Impact of Continuous and Pulsatile-Flow Left Ventricular Assist Devices on Post-Transplant Rejection Urban, M.
 2013
 32 4S p. S275-
1 p.
 artikel
359 Impact of Demographic and On-Pump Factors on Post-Transplant Survival Following Support with the HVAD System John, R.
 2013
 32 4S p. S24-S25
2 p.
 artikel
360 Impact of Different Indications for HU Listing of VAD Patients on Survival after Heart Transplantation Schulz, U.
 2013
 32 4S p. S164-
1 p.
 artikel
361 Impact of Donor-Recipient Sex Matchup on Survival after Heart Transplantation in Children: An Analysis of >6000 Pediatric Heart Transplants Kemna, M.
 2013
 32 4S p. S192-
1 p.
 artikel
362 Impact of Duration of “Agonal Time” during the Controlled Donation after Circulatory Death (DCD) on Early and Mid-Term Results of Lung Transplantation (LTx) Zych, B.
 2013
 32 4S p. S152-
1 p.
 artikel
363 Impact of Early Adverse Events (AE’s) on Later Mortality in Patients Supported by Continuous-Flow Ventricular Assist Devices (CF-VAD) Jackson, K.
 2013
 32 4S p. S272-S273
2 p.
 artikel
364 Impact of Enoximone on Ischemia Reperfusion Injury-Induced Myocardial Mitochondria Damage Sommer, S.-P.
 2013
 32 4S p. S299-
1 p.
 artikel
365 Impact of Heart Donor “Inotrope” Support on 30-Day Graft Outcomes in Heart Transplantation Copeland, H.
 2013
 32 4S p. S122-
1 p.
 artikel
366 Impact of Immunosuppressive Therapy on Anti-EBV Specific CD8+T-Cells in Pediatric Heart Transplant Recipients Hingler, S.
 2013
 32 4S p. S191-S192
2 p.
 artikel
367 Impact of Lung Allocation Score on Transplantation Activity and Outcomes – Initial German Experience Greer, M.
 2013
 32 4S p. S59-
1 p.
 artikel
368 Impact of Mechanical Support on Quality of Life Measures over Time Teuteberg, J.J.
 2013
 32 4S p. S100-
1 p.
 artikel
369 Impact of Parenteral Treprostinil Dosing in Pulmonary Arterial Hypertension Preston, I.R.
 2013
 32 4S p. S64-S65
2 p.
 artikel
370 Impact of Recipient Age on Differential Causes of Heart Transplant Mortality. Is It Time To Personalize Post-Transplant Management? Wever-Pinzon, O.
 2013
 32 4S p. S13-
1 p.
 artikel
371 Impact of Right Ventricular Performance Load Dependency on Preoperative Prediction of Postoperative Right Heart Function in Patients Who Need a Left Ventricular Assist Device Dandel, M.
 2013
 32 4S p. S286-
1 p.
 artikel
372 Impact of Sex Mismatch on Overall and Cardiac Survivals in Male Heart Recipients: A 21-Year French Experience Vermes, E.
 2013
 32 4S p. S257-S258
2 p.
 artikel
373 Implantable Cardioverter-Defibrillators Do Not Reduce Mortality in Patients with the HeartMate II Left Ventricular Assist Device Enriquez, A.
 2013
 32 4S p. S25-
1 p.
 artikel
374 Implantable Ventricular Assist Device Use in the Immunosuppressed Patient Jones, S.
 2013
 32 4S p. S274-
1 p.
 artikel
375 Improved Outcomes in Left Ventricular Assist Device Therapy for Patients between 65 and 70 Years Deo, S.
 2013
 32 4S p. S183-S184
2 p.
 artikel
376 Improved Postoperative Clinical Outcomes after Ventricular Assist Device Implantation in Patients Older Than 60 Years of Age at the University of Wisconsin Hospital and Clinics Lushaj, E.B.
 2013
 32 4S p. S237-
1 p.
 artikel
377 Improved Survival with Perioperative Desensitization in Lung Transplant Patients with Donor Specific Antibodies (DSA) Tinckam, K.
 2013
 32 4S p. S75-
1 p.
 artikel
378 Improvement in Severe Kidney Dysfunction after Implantation of Continuous-Flow Left Ventricular Assist Devices Saxena, S.
 2013
 32 4S p. S275-
1 p.
 artikel
379 Improvements in Pulmonary Hemodynamics Persist after Heart Transplant in Patients Bridged with Continuous-Flow LVAD (CF-LVAD) Kamdar, F.
 2013
 32 4S p. S184-
1 p.
 artikel
380 Improving Outcomes in Children Requiring Mechanical Bridge-To-Transplantation (BTT) in the Current Era Davies, R.R.
 2013
 32 4S p. S107-
1 p.
 artikel
381 Improving Outcomes in Lung Transplantation for Cystic Fibrosis – A Unified Approach Ranasinghe, A.M.
 2013
 32 4S p. S215-S216
2 p.
 artikel
382 Incidence and Characterization of Percutaneous Lead Damage in the Heartmate II Left Ventricular Assist Device Kalavrouziotis, D.
 2013
 32 4S p. S85-
1 p.
 artikel
383 Incidence and Importance of New Postoperative Right Bundle Branch Block after Pediatric Orthotopic Heart Transplantation Ramey, J.
 2013
 32 4S p. S193-S194
2 p.
 artikel
384 Incidence and Pre-Implant Predictors of Late Right Ventricular Failure in Patients Supported with Contineous-Flow LVADs Aldeiri, M.
 2013
 32 4S p. S182-S183
2 p.
 artikel
385 Incidence of Allograft Vasculopathy in the TICTAC Trial as Compared to a Real World Cohort Baran, D.A.
 2013
 32 4S p. S26-
1 p.
 artikel
386 Incidence of Increases in Pump Power Utilization and Associated Clinical Outcomes in Patients Who Have Undergone Heartmate II Implantation Steffen, R.J.
 2013
 32 4S p. S70-S71
2 p.
 artikel
387 Incidence of Malignancy on Tacrolimus Monotherapy Versus Combination Therapy: A Report from the TICTAC Trial Baran, D.A.
 2013
 32 4S p. S40-
1 p.
 artikel
388 Incidence of Proteinuria after Initiation of Everolimus in Heart Transplantion. May It Have Repercussion on Renal Function? Paniagua-Martín, M.J.
 2013
 32 4S p. S262-
1 p.
 artikel
389 Increased ADORA2B Expression Correlates with Mean Pulmonary Arterial Pressure in Idiopathic Pulmonary Fibrosis Garcia-Morales, L.J.
 2013
 32 4S p. S63-
1 p.
 artikel
390 Increased Frequency of Class II HLA-DQ Donor-Specific Antibodies Is Associated with Mixed Cellular and Humoral Rejection in Lung Transplantation Zeevi, A.
 2013
 32 4S p. S76-
1 p.
 artikel
391 Increased Incidence of PTLD in Adult Lung Transplant Recipients with Cystic Fibrosis: Analysis of the International Society for Heart and Lung Transplantation Registry Lowery, E.M.
 2013
 32 4S p. S145-
1 p.
 artikel
392 Increased Myocardial Extracellular Volume in New-Onset Non-Ischemic Cardiomyopathy Assessed by Cardiovascular Magnetic Resonance Imaging Radunski, U.K.
 2013
 32 4S p. S207-S208
2 p.
 artikel
393 Increased Negative Impact of Anti-Angiotensin Type 1 Receptor Antibodies Together with De Novo Donor HLA Specific Antibodies on Graft Outcome in Heart Transplant Recipients Reinsmoen, N.L.
 2013
 32 4S p. S113-
1 p.
 artikel
394 Increasing Creatine Phosphokinase and Myglobine Levels Predict the Development of Acute Renal Failure Immediately after Combined Heart-Lung Transplantation Salman, J.
 2013
 32 4S p. S271-S272
2 p.
 artikel
395 Increasing Heart Donation: Results of a Multi-Ethnic Population-Based Survey from Turkey Yerebakan, H.
 2013
 32 4S p. S160-
1 p.
 artikel
396 Indices of Right Ventricular Contractility in a Model of Chronic Pulmonary Hypertension Guihaire, J.
 2013
 32 4S p. S78-
1 p.
 artikel
397 Induction Therapy in African American Heart Transplant Recipients: Analysis of the UNOS Database Coleman, B.
 2013
 32 4S p. S134-S135
2 p.
 artikel
398 Infant B-Cell Signaling after ABO-Incompatible Heart Transplantation (ABOi HTx): Defining the Role of the Inhibitory Molecule CD22 Derkatz, K.
 2013
 32 4S p. S298-S299
2 p.
 artikel
399 Infection Control and Prevention Practices for Mechanical Circulatory Support: An International Survey Kusne, S.
 2013
 32 4S p. S182-
1 p.
 artikel
400 Infectious Complications and Outcomes in Children Supported with Left Ventricular Assist Devices Cabrera, A.G.
 2013
 32 4S p. S84-
1 p.
 artikel
401 Inflammatory Cell Burden and Phenotype in Endomyocardial Biopsies from Patients with Antibody-Mediated Rejection (AMR) – An AECVP Multicenter Study Fedrigo, M.
 2013
 32 4S p. S19-
1 p.
 artikel
402 Influence of Cytomegalovirus (CMV) Infection in the Development of Cardiac Allograft Vasculopathy (CAV) in Heart Transplants Recipients (HT) Delgado, J.F.
 2013
 32 4S p. S51-
1 p.
 artikel
403 Influence of Everolimus-Based Immunosuppression on Infections in Heart Transplant Recipients Ohdah, S.
 2013
 32 4S p. S190-
1 p.
 artikel
404 Influence of Genetic Variation in Pharmacokinetic (PK) and -Dynamic (PD) Pathways of Immunosuppressants on Drug Response in Heart Transplant Patients Sigurdardottir, V.
 2013
 32 4S p. S135-
1 p.
 artikel
405 Influence of Liver and Renal Impairments on Early Mortality in Heart Transplant Patients Lebray, P.
 2013
 32 4S p. S52-
1 p.
 artikel
406 Influence of Partial Mechanical Left Ventricular Support on Metabolism of Neuroendocrine Hormones and Exercise Capacity Welp, H.A.
 2013
 32 4S p. S175-
1 p.
 artikel
407 Influence of Pre-Transplant Chronic Kidney Disease (CKD) on Adult Heart Transplant (HT) Outcomes DePasquale, E.C.
 2013
 32 4S p. S166-
1 p.
 artikel
408 Influence of Race/Ethnic Differences in Pre-Transplant Panel Reactive Antibody on Outcomes in Heart Transplant Recipients Morris, A.A.
 2013
 32 4S p. S14-S15
2 p.
 artikel
409 Inhaled Immunosuppression Using the Novel JAK1/3 Inhibitor R507 Deuse, T.
 2013
 32 4S p. S82-S83
2 p.
 artikel
410 Injectable Matrix Bioscaffolds Improve LV Function and Stimulate Cardiomyocyte Regeneration in Infarcted Hearts Boyd, W.D.
 2013
 32 4S p. S46-
1 p.
 artikel
411 Innovative Roles To Support Advanced Heart Failure & Transplant Program Growth Nelson, K.E.
 2013
 32 4S p. S125-
1 p.
 artikel
412 Insights into Heart Transplantation for Protein Losing Enteropathy: A 24 Year Experience Gambetta, K.
 2013
 32 4S p. S193-
1 p.
 artikel
413 Institutional Volume of Heart Transplantation with Left Ventricular Assist Device Explantation Influences Graft Survival Maltais, S.
 2013
 32 4S p. S24-
1 p.
 artikel
414 Insulin Growth Factor 1 and Cardiac Allograft Vasculopathy Alharethi, R.
 2013
 32 4S p. S209-
1 p.
 artikel
415 Integration of Nurse Practitioner Clinical Practice Model into Outpatient Heart Transplant Clinic Chambers, S.V.
 2013
 32 4S p. S197-
1 p.
 artikel
416 Integrative Omics of Aspiration in Lung Transplantation Neujahr, D.C.
 2013
 32 4S p. S250-
1 p.
 artikel
417 Interleukin-17 Tissue Expression Correlates with Severity of Acute and Chronic Allograft Rejection in Rat Orthotopic Lung Transplantation Calabrese, F.
 2013
 32 4S p. S263-S264
2 p.
 artikel
418 INTERMACS Level at the Time of Transplant Assessment Predicts Overall Mortality and Probability of Advanced Therapy Alba, A.C.
 2013
 32 4S p. S112-
1 p.
 artikel
419 INTERMACS Profiling Identifies Risk of Death or VAD among Medically-Managed Advanced Heart Failure Patients Stewart, G.C.
 2013
 32 4S p. S133-
1 p.
 artikel
420 Intracoronary Treatment with VEGF-C/D Inhibitor Enhances Cardiac Allograft Survival and Prevents Chronic Rejection by Regulating Lymphatic Endothelial Cell Activation Dashkevich, A.
 2013
 32 4S p. S32-S33
2 p.
 artikel
421 Intraoperative Extracorporeal Membrane Oxygenation as an Alternative to Cardiopulmonary Bypass in Lung Transplantation Odell, D.D.
 2013
 32 4S p. S167-S168
2 p.
 artikel
422 Intravenous Treprostinil Delivered by the Implantable Pump Lenus Pro®: A Innovative “Surgical” Approach to Management of PAH Steringer-Mascherbauer, R.
 2013
 32 4S p. S64-
1 p.
 artikel
423 In Vitro Modeling of Duchenne Muscular Dystrophy (DMD) Cardiomyopathy Using Human Induced Pluripotent Stem Cells (hiPSC) Kamdar, F.
 2013
 32 4S p. S245-
1 p.
 artikel
424 In Vivo Profiling of T-Cell Responses by Omental Cells (OC) in Experimental Lung Transplantation (LTx) Medina, M.
 2013
 32 4S p. S70-
1 p.
 artikel
425 In Vivo Testing of a Novel Blood Pump for Short-Term Extracorporeal Life Support Teman, N.R.
 2013
 32 4S p. S148-S149
2 p.
 artikel
426 Is Intermittent Hemodialysis Safe in Patients with a Continuous Flow Left Ventricular Assist Device? Quader, M.A.
 2013
 32 4S p. S176-S177
2 p.
 artikel
427 Is Lactate Level during Warm Perfusion a Predictor for Post Transplant Outcomes? Deng, M.
 2013
 32 4S p. S156-S157
2 p.
 artikel
428 Is Ventricular Assist Device an Effective Tool To Support Children with a Failing Cardiac Graft? Adachi, I.
 2013
 32 4S p. S288-
1 p.
 artikel
429 It’s Not the Bad Guys. A Differentiated View on Post HTX Adherence: Medication, Mental Health, Hygienic Behavior Tigges-Limmer, K.
 2013
 32 4S p. S80-S81
2 p.
 artikel
430 Japanese Experience of EVAHEART TM Left Ventricular Assist System Saito, S.
 2013
 32 4S p. S11-S12
2 p.
 artikel
431 Kidney-Induced Cardiac Allograft Tolerance across a Full MHC-Barrier in Miniature Swine Michel, S.G.
 2013
 32 4S p. S68-
1 p.
 artikel
432 Lactate Dehydrogenase Is Superior to Serum Free Hemoglobin as a Marker of Pump Thrombosis in Left Ventricular Assist Devices Shah, P.
 2013
 32 4S p. S37-
1 p.
 artikel
433 Large-Airway Lymphocytic Bronchitis Predicts Bronchiolitis Obliterans Syndrome Greenland, J.R.
 2013
 32 4S p. S59-
1 p.
 artikel
434 Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors Masetti, M.
 2013
 32 4S p. S33-S34
2 p.
 artikel
435 Late Onset Infection in Patients with Ventricular Assist Devices: Etiology, Management and Outcomes Tong, M.Z.
 2013
 32 4S p. S187-
1 p.
 artikel
436 Late Right Heart Failure after Left Ventricular Assist Device Implantation: Clinical Predictors and Outcomes Saxena, S.
 2013
 32 4S p. S31-
1 p.
 artikel
437 Left Internal Thoracic Artery (LITA) Anastomoses with Coronary Microcirculation in Rat: Vineberg Procedure Revisited Villet, O.M.
 2013
 32 4S p. S299-
1 p.
 artikel
438 Left Ventricular Assist Device in Right Ventricular Failure Parwani, P.
 2013
 32 4S p. S83-
1 p.
 artikel
439 Left Ventricular Assist Device (LVAD) Outcomes Are Not Adversely Affected by Geographic Variables Vader, J.M.
 2013
 32 4S p. S180-
1 p.
 artikel
440 Left Ventricular Assist Device Placement in Very Obese Patients: Proceed with Caution Osaki, S.
 2013
 32 4S p. S224-S225
2 p.
 artikel
441 Left Ventricular Dysfunction after Lung Transplantation in Pulmonary Hypertension Patients Gupta, S.
 2013
 32 4S p. S270-
1 p.
 artikel
442 Life on the Heart Transplant Waiting List: Life on Hold? Life at All? Mauthner, O.
 2013
 32 4S p. S196-
1 p.
 artikel
443 Liver Cirrhosis in Fontan Patients Does Not Affect One Year Post-Heart Transplant Mortality or Markers of Liver Function Simpson, K.E.
 2013
 32 4S p. S36-
1 p.
 artikel
444 Liver Dysfunction and Early Mortality after Heart Transplant Kobulnik, J.
 2013
 32 4S p. S164-S165
2 p.
 artikel
445 Lobar Lung Transplantation for High Risk Patients – Lessons from the Initial Experience Shigemura, N.
 2013
 32 4S p. S61-S62
2 p.
 artikel
446 Lobar Lung Transplantation – Is It Comparable to Standard Lung Transplantation? Slama, A.
 2013
 32 4S p. S267-
1 p.
 artikel
447 Longer and Shorter Hospital Stay after Heart Transplant Both Risk Factors for Suboptimal Outcome Kittleson, M.
 2013
 32 4S p. S263-
1 p.
 artikel
448 Longitudinal Holistic Profiling of the Lung Transplant Microbiome Willner, D.
 2013
 32 4S p. S10-S11
2 p.
 artikel
449 Longitudinal Investigation of the Effect of Centrifugal Continuous Flow LVADS on Blood Haemostatic Parameters Muthiah, K.
 2013
 32 4S p. S118-
1 p.
 artikel
450 Longitudinal Study of Pulmonary Microbial Dynamics in Lung Transplant Recipients with and without Bronchiolitis Obliterans Syndrome Poroyko, V.
 2013
 32 4S p. S34-
1 p.
 artikel
451 Long Term Heart Failure Management in Children with Dilated Cardiomyopathy Rusconi, P.
 2013
 32 4S p. S239-S240
2 p.
 artikel
452 Long Term Outcome after Bronchial Artery Revascularization in Double Lung Transplantation – A More Than Fifteen Year Follow-Up Study Perch, M.
 2013
 32 4S p. S219-
1 p.
 artikel
453 Long-Term Outcome of Renal Function with Everolimus Treatment in a Pediatric Center Behnke-Hall, K.
 2013
 32 4S p. S192-
1 p.
 artikel
454 Long Term Outcomes for LVAD Patients Who Underwent Speed Optimization Using Pre-Discharge Ramp Test Uriel, N.
 2013
 32 4S p. S182-
1 p.
 artikel
455 Long-Term Outcomes of Lung Transplantation (LT) in Hepatitis C Positive (HCV+) Patients Garcha, P.
 2013
 32 4S p. S48-
1 p.
 artikel
456 Long-Term Outcomes of Orthotopic Heart Transplantation in Patients with Cardiac Amyloidosis: Differential Survival by Amyloid Type Yerebakan, H.
 2013
 32 4S p. S111-
1 p.
 artikel
457 Long-Term Renoprotective Effect of Sirolimus-Based Calcineurin Inhibitor-Free Immunosuppression after Cardiac Transplantation Choi, J.-O.
 2013
 32 4S p. S115-
1 p.
 artikel
458 Long-Term Results of Transplantation of Normothermic Ex-Vivo Perfused Donor Lungs Tikkanen, J.M.
 2013
 32 4S p. S146-S147
2 p.
 artikel
459 Long Term Results with Total Artificial Heart: Is It Prime Time for Destination Therapy? Torregrossa, G.
 2013
 32 4S p. S118-
1 p.
 artikel
460 Long-Term Survival after Heart Transplantation Depends on Proper Outward Remodeling of Epicardial Arteries with Cardiac Allograft Vasculopathy Huibers, M.M.H.
 2013
 32 4S p. S242-
1 p.
 artikel
461 Long-Term Survival and Prognostic Markers in 1000 Patients with Advanced Heart Failure. A Single-Center Analysis Lesny, P.
 2013
 32 4S p. S167-
1 p.
 artikel
462 Losing the War before the First Battle: Explant Malignancy in Lung Transplantation Brown, C.R.
 2013
 32 4S p. S214-
1 p.
 artikel
463 Low Dose Factor Eight Inhibitor Bypassing Activity (FEIBA) for Incessant Bleeding in Pediatric Patients on Mechanical Circulatory Support (MCS) Maeda, K.
 2013
 32 4S p. S290-
1 p.
 artikel
464 Low Rate of Allosensitization Associated with the Syncardia Total Artifical Heart and the Heartmate II LVAD Tang, D.G.
 2013
 32 4S p. S237-
1 p.
 artikel
465 Low Serum Total Cholesterol and Triglycerides Are Associated with Adverse Events in Advanced Heart Failure: The “Lipid Paradox” in MEDAMACS Testani, J.
 2013
 32 4S p. S133-S134
2 p.
 artikel
466 Lung Injuries Induced by Gastric Acid Aspiration Are Attenuated by Exogenous Surfactant during Ex Vivo Reconditioning in Pigs Khalife, T.
 2013
 32 4S p. S47-
1 p.
 artikel
467 Lung Size Mismatch and Primary Graft Dysfunction after Bilateral Lung Transplantation Eberlein, M.
 2013
 32 4S p. S41-
1 p.
 artikel
468 Lung Size Mismatch and Survival after Bilateral Lung Transplantation for Idiopathic Pulmonary Arterial Hypertension Eberlein, M.
 2013
 32 4S p. S146-
1 p.
 artikel
469 Lung Transplantation for Diffuse Panbronchiolitis Sugimoto, S.
 2013
 32 4S p. S188-
1 p.
 artikel
470 Lung Transplantation for Pulmonary Lymphangioleiomyomatosis: Single-Centre Experience Salman, J.
 2013
 32 4S p. S221-S222
2 p.
 artikel
471 Lung Transplantation from Donation after Cardiac Death – 3 Years Single Centre Experience Hashmi, S.F.
 2013
 32 4S p. S217-
1 p.
 artikel
472 Lung Transplantation: Making Sense of the Sensitized Westall, G.P.
 2013
 32 4S p. S169-S170
2 p.
 artikel
473 Lung Transplantation Outcomes in “Older” Patients: Risk vs. Benefit? Ibrahim, S.
 2013
 32 4S p. S269-S270
2 p.
 artikel
474 Lung Transplant Outcomes for High-Risk Patients (LAS≥50) with Idiopathic Pulmonary Fibrosis (IPF) Osaki, S.
 2013
 32 4S p. S267-S268
2 p.
 artikel
475 Lung Transplant Recipients Suspected of Antibody Mediated Rejection Treated with Plasmapheresis Have a Poor Prognosis Dirks, C.G.
 2013
 32 4S p. S264-
1 p.
 artikel
476 LVAD-Associated Coagulopathy: Contribution of Phosphatidylserine (PS+) Cellular Microparticles to the Risk of Hemorrhage and Thrombosis in Patients with Non-Pulsatile Left Ventricular Assist Devices Nascimbene, A.
 2013
 32 4S p. S117-
1 p.
 artikel
477 LVAD Explant to Recovery in Females Following Prolonged Support Cheyne, C.A.
 2013
 32 4S p. S282-S283
2 p.
 artikel
478 LVAD-Induced Improvement in Myocardial Function Is Associated with a Unique Pattern of Circulating microRNAs Galenko, O.
 2013
 32 4S p. S148-
1 p.
 artikel
479 LV Unloading with Continuous-Flow Left Ventricular Assist Devices: The Association Between Left Ventricular Size and Late Survival Nagpal, A.D.
 2013
 32 4S p. S179-
1 p.
 artikel
480 Lymphatic CD68+ Endothelial Cells in Cardiac Allograft Humoral Rejection Beletskaya, L.V.
 2013
 32 4S p. S202-
1 p.
 artikel
481 Magnitude and Time Course of Changes Induced by Continuous-Flow Left Ventricular Assist Device Unloading in Chronic Heart Failure: Insights into Cardiac Recovery Wever-Pinzon, O.
 2013
 32 4S p. S31-S32
2 p.
 artikel
482 Maintenance Steroid Use and Outcomes of Pediatric Heart Transplantation: A Propensity Matched Analysis of the Pediatric Heart Transplant Study (PHTS) Database Auerbach, S.R.
 2013
 32 4S p. S36-S37
2 p.
 artikel
483 Management and Outcomes of Ventricular Assist Device Patients with Suspected Pump Thrombosis Lenneman, A.J.
 2013
 32 4S p. S186-S187
2 p.
 artikel
484 Management of Anticoagulation in Patients with Mechanical Circulatory Support Using a Physician-Based Versus a Pharmacist Directed Anticoagulation Clinic-Based Strategy Teuteberg, J.J.
 2013
 32 4S p. S294-S295
2 p.
 artikel
485 Managing Bronchial Anastomotic Complications – The Influence of Aspergillosis Kenny, L.A.
 2013
 32 4S p. S266-
1 p.
 artikel
486 MAPK/ERK Pathway Activation Leads to Severe Ischemia-Reperfusion-Induced Lung Injury Okada, M.
 2013
 32 4S p. S138-
1 p.
 artikel
487 Maximal Exercise Response Is Reduced in Patients with the Total Artificial Heart Canada, J.M.
 2013
 32 4S p. S91-
1 p.
 artikel
488 Measurement of Blood Pressure during Support with a Continuous-Flow Left Ventricular Assist Device in the Outpatient Setting Coyle, L.A.
 2013
 32 4S p. S235-
1 p.
 artikel
489 Measurement of Left Ventricular Chamber Function in the Setting of Ventricular Assist Device Support Gupta, S.
 2013
 32 4S p. S55-
1 p.
 artikel
490 Mechanical Circulatory Support: When Less Is More Leviner, D.B.
 2013
 32 4S p. S138-S139
2 p.
 artikel
491 Mechanical Unloading through Ventricular Assist Devices Increases Myocardial Content of Unsaturated Acyl-CoA Species in Patients with Advanced Heart Failure Ji, R.
 2013
 32 4S p. S163-
1 p.
 artikel
492 Meeting INR Targets for the Left Ventricular Assist Device Patient Schaefer, S.A.
 2013
 32 4S p. S116-S117
2 p.
 artikel
493 Men Versus Women: Outcome Differences on Cyclosporine and Tacrolimus Rush, J.
 2013
 32 4S p. S201-
1 p.
 artikel
494 Mesenchymal Stem Cell Pretreatment of Non-Heart-Beating-Donors in Experimental Lung Transplantation – Initial Experience Wittwer, T.
 2013
 32 4S p. S15-S16
2 p.
 artikel
495 Mesenchymal Stem Cells Attenuates Ischemia Reperfusion Injury after Orthotopic Lung Transplantation in a Mouse Model Watanabe, T.
 2013
 32 4S p. S69-
1 p.
 artikel
496 Metabolites in Human Ex Vivo Lung Perfusates Are Differentially Affected in Brain Death (BDD) vs. Cardiac Death Donors (DCD) and Modified by Duration of Normothermic Perfusion Hsin, M.K.
 2013
 32 4S p. S151-S152
2 p.
 artikel
497 Metabolomic Profile of Rat Lung Tissue after Death: Effect of Delayed Post-Mortem O2-Ventilation Egan, T.
 2013
 32 4S p. S296-S297
2 p.
 artikel
498 Micro-And Macrovascular Function in End Stage Heart Failure: Influence of Mechanical Circulatory Support and of Heart Transplant Sansone, R.
 2013
 32 4S p. S188-
1 p.
 artikel
499 Micro-RNA-451 and Measures of Hemolysis Associated with Left Ventricular Assist Device Implantation Givens, R.C.
 2013
 32 4S p. S279-
1 p.
 artikel
500 Microvascular Remodeling on Endomyocardial Biopsy and Coronary Flow Reserve by Transthoracic Doppler Echocardiography in Heart Transplant Patients: A Clinical-Pathological Study Fedrigo, M.
 2013
 32 4S p. S242-S243
2 p.
 artikel
501 Minimal-Invasive LVAD Implantation, Is It Safe or Even Better? Meyer, A.L.
 2013
 32 4S p. S58-
1 p.
 artikel
502 Minimally-Invasive Implantation of Left Ventricular Assist Devices Improves the Operative Outcome in Adult Patients with Severe Heart Failure Rojas, S.V.
 2013
 32 4S p. S142-
1 p.
 artikel
503 miRNA Modulation of Adiponectin Receptor 2 in Myocardium of Patients with End-Stage Heart Failure Beiras-Fernandez, A.
 2013
 32 4S p. S97-
1 p.
 artikel
504 Mitigating Lung Ischemia-Reperfusion Injury in Miniature Swine Madariaga, M.L.L.
 2013
 32 4S p. S298-
1 p.
 artikel
505 Mode of Death in Patients with Pulmonary Arterial Hypertension Vizza, C.D.
 2013
 32 4S p. S17-S18
2 p.
 artikel
506 Modification of the Psychosocial Assessment of Candidates for Transplantation (PACT) Improves Risk Classification and Prediction of Hospital Readmission of MCS Patients Maltby, M.C.
 2013
 32 4S p. S79-
1 p.
 artikel
507 Modifications of the Skeletal Muscle Ryanodine Receptor Type 1 and Exercise Intolerance in Heart Failure Rullman, E.
 2013
 32 4S p. S248-
1 p.
 artikel
508 Molecular Definition of the Multiorgan Dysfunction Syndrome in Mechanical Circulatory Therapy for Advanced Heart Failure Cadeiras, M.
 2013
 32 4S p. S177-S178
2 p.
 artikel
509 Monitoring Dedifferentiation of Cardiomyocytes in the Human Diseased Myocardium Richter, M.H.
 2013
 32 4S p. S162-S163
2 p.
 artikel
510 Mortality Differences after Heart Transplantation in Patients Bridged with Balloon Pumps vs. Left Ventricular Assist Devices Castleberry, A.W.
 2013
 32 4S p. S23-S24
2 p.
 artikel
511 Multicenter Canadian Experience with the HeartWare HVAD Rao, V.
 2013
 32 4S p. S12-
1 p.
 artikel
512 Mycophenolate Not Azathioprine Is Associated with Increased Risk for Skin Cancer after Heart Transplant Piponniau, L.
 2013
 32 4S p. S199-
1 p.
 artikel
513 Myocardial Recovery after Ventricular Unloading with Pulsatile- Versus Continuous-Flow Assist Device Wagner, F.M.
 2013
 32 4S p. S283-S284
2 p.
 artikel
514 Natural History of Tricuspid Valve Regurgitation (TR) Diagnosed Immediately after Heart Transplant Zanotti, G.
 2013
 32 4S p. S256-
1 p.
 artikel
515 Neopterin Predicts Poor Short- and Long-Term Outcomes in Heart Transplant Recipients Shevchenko, O.P.
 2013
 32 4S p. S52-
1 p.
 artikel
516 Neurodevelopment Outcomes Following Heart Transplant Deliva, R.D.
 2013
 32 4S p. S124-
1 p.
 artikel
517 Neurological Outcomes Associated with Use of the Berlin Heart EXCOR © Pediatrics Jordan, L.C.
 2013
 32 4S p. S107-S108
2 p.
 artikel
518 New Insights in Bronchiolitis Obliterans Syndrome after Lung Transplantation Using (micro-)CT Verleden, S.E.
 2013
 32 4S p. S103-S104
2 p.
 artikel
519 No Harm, No Foul? The Prospective Treatment of Sensitized Heart Transplant Recipients with Plasmapheresis and IVIG-Five Year Follow-Up Weston, M.W.
 2013
 32 4S p. S87-
1 p.
 artikel
520 Non-Depleting Induction Immunosuppression Is Associated with Less Clinically Significant Acute Cellular Rejection in Pediatric Heart Transplantation Recipients Jeffers, K.D.
 2013
 32 4S p. S241-
1 p.
 artikel
521 Noninvasive Predictors of Diastolic Dysfunction in Children after Cardiac Transplant DiPietro, A.
 2013
 32 4S p. S190-
1 p.
 artikel
522 Non-Responders to Antiplatelet Therapy in Patients with Left Ventricular Assist Devices Riebandt, J.
 2013
 32 4S p. S174-
1 p.
 artikel
523 Non-Transplantation of Hearts When There Is Consent for Donation: A UK National Study Dronavalli, V.B.
 2013
 32 4S p. S157-
1 p.
 artikel
524 Normothermic Ex Vivo Lung Perfusion as an Assessment of Marginal Donor Lungs – The NOVEL Lung Trial Sanchez, P.G.
 2013
 32 4S p. S16-S17
2 p.
 artikel
525 North American Results from the Multicenter Randomized Trial of Everolimus vs Mycophenolate Mofetil in Heart Transplantation Kobashigawa, J.
 2013
 32 4S p. S201-
1 p.
 artikel
526 Novel Model To Assess Prognosis of Transplant Vasculopathy Following Cardiac Transplantation Hiemann, N.E.
 2013
 32 4S p. S27-
1 p.
 artikel
527 Novoseven Use To Reduce Peri-Operative Bleeding Following HeartMate II Implant Snyder, T.A.
 2013
 32 4S p. S175-
1 p.
 artikel
528 Nutrition in the CF Population: Impact on Wait-List and Post-Transplant Survival, a Single Center’s Experience Mahoney, E.
 2013
 32 4S p. S44-
1 p.
 artikel
529 Obesity and Lung Transplants – It’s an Age Thing Aruede, G.I.O.
 2013
 32 4S p. S215-
1 p.
 artikel
530 Observational Epidemiological Study To Assess Cardiovascular Risk Factors in Heart Transplant Recipients in Spain (CTC Study): Preliminary Results at 18 Months Post-Transplantation Rábago, G.
 2013
 32 4S p. S205-S206
2 p.
 artikel
531 Office and Home Systolic Blood Pressures Are Underestimated in Heart Transplant Recipients Aquilante, C.L.
 2013
 32 4S p. S262-S263
2 p.
 artikel
532 Open Chest Epicardial Ablation of Ventricular Tachycardia Early after Left Ventricular Assist Device Implantation Raissi Shabari, F.
 2013
 32 4S p. S272-
1 p.
 artikel
533 Optimal Lung Inflation Techniques under the Current Standard Lung Protection Protocol in a Rat Lung Transplantation Model Tanaka, Y.
 2013
 32 4S p. S246-S247
2 p.
 artikel
534 Optimizing the Estimation of Renal Function in Lung Transplant Candidates Osho, A.A.
 2013
 32 4S p. S217-
1 p.
 artikel
535 Oral Ribavirin Is a Cost-Effective Alternative to Intravenous Ribavirin for Respiratory Syncytial Virus (RSV) Infection after Lung Transplantation (LTx) Burrows, F.S.
 2013
 32 4S p. S109-
1 p.
 artikel
536 Origin of Fibroblasts in Rejected Airway: Experiment with Orthotopic Tracheal Allotransplantation Model Using Transgenic GFP Mice Konoeda, C.
 2013
 32 4S p. S121-
1 p.
 artikel
537 Osteopontin Lung Expression Is a Marker of Disease Severity in Pulmonary Arterial Hypertension Mura, M.
 2013
 32 4S p. S18-
1 p.
 artikel
538 Outcome after Lung Transplantation Is Comparable between DCD and DBD Van Raemdonck, D.
 2013
 32 4S p. S122-
1 p.
 artikel
539 Outcome of Adults with Congenital Heart Disease Evaluated for Heart Transplant: A Multi-Center Study Boucek, D.
 2013
 32 4S p. S165-S166
2 p.
 artikel
540 Outcome of Patients with Right Ventricular Failure on Milrinone after Left Ventricular Assist Device Implantation Morgan, J.A.
 2013
 32 4S p. S282-
1 p.
 artikel
541 Outcomes after Lung Transplantation for Cystic Fibrosis: A Single Center Experience Morisset, J.
 2013
 32 4S p. S268-
1 p.
 artikel
542 Outcomes after Orthotopic Heart and Heart-Lung Transplantation for Congenital Heart Disease in Australia and New Zealand Hatzistergos, J.
 2013
 32 4S p. S13-S14
2 p.
 artikel
543 Outcomes after Ventricular Assist Device Support in Patients Bridged with Temporary Circulatory Support: Analysis from INTERMACS Shreenivas, S.
 2013
 32 4S p. S141-S142
2 p.
 artikel
544 Outcomes Associated Mycobacterium xenopi (M. xenopi) Infections in Lung Transplant Recipients (LTRs) Hryckiewicz, K.
 2013
 32 4S p. S190-
1 p.
 artikel
545 Outcomes in Lung and Combined Heart-Lung Transplantation for Congenital Heart Disease Beaty, C.A.
 2013
 32 4S p. S147-
1 p.
 artikel
546 Outcomes in Patients with Ischemic Cardiomyopathy (ICM) Post-Heart Transplant (HT) by Era DePasquale, E.C.
 2013
 32 4S p. S112-
1 p.
 artikel
547 Outcomes of Adult Heart (HT) Versus Heart-Kidney (H+K) Transplant: Influence of CKD (Chronic Kidney Disease) Stage DePasquale, E.C.
 2013
 32 4S p. S144-
1 p.
 artikel
548 Outcomes of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Post Heart Transplant (HT) DePasquale, E.C.
 2013
 32 4S p. S23-
1 p.
 artikel
549 Outcomes of Heart Transplant (HT) Recipients Bridged with ECMO DePasquale, E.C.
 2013
 32 4S p. S141-
1 p.
 artikel
550 Outcomes of Long-Term Veno-Venous Extracorporeal Membrane Oxygenation Support for Acute Respiratory Distress Syndrome Kon, Z.N.
 2013
 32 4S p. S218-
1 p.
 artikel
551 Outcomes of Minimally Invasive vs. Conventional Implantation of Continuous Flow Left Ventricualr Assist Device: A Single Center Experience Toma, M.
 2013
 32 4S p. S179-S180
2 p.
 artikel
552 Outcomes of Orthotopic Heart Transplantation with Extended Allograft Ischemic Time Polgar, A.
 2013
 32 4S p. S52-
1 p.
 artikel
553 Outcomes of Patients with Peripartum Cardiomyopathy Who Received Mechanical Circulatory Support: Data from the INTERMACS Registry Loyaga-Rendon, R.
 2013
 32 4S p. S12-
1 p.
 artikel
554 Outcomes of Third Heart Transplants in Pediatric and Young Adult Patients Friedland-Little, J.M.
 2013
 32 4S p. S191-
1 p.
 artikel
555 Outcomes with High Pre-Transplant PRA in Pediatric Heart Transplantation at a Single Center Dodd, D.A.
 2013
 32 4S p. S240-
1 p.
 artikel
556 Outpatient Inotropes: An Ever-Lengthening Bridge to Transplant Hall, S.A.
 2013
 32 4S p. S165-
1 p.
 artikel
557 Outward Remodeling of Coronary Arteries in Cardiac Allograft Vasculopathy Is Reduced Compared to Native Atherosclerosis Miller, D.V.
 2013
 32 4S p. S244-S245
2 p.
 artikel
558 Overall Outcomes of Patients with Left Ventricular Assist Devices (LVADs) in Acute Rehabilitation Facility: How Safe Are These Patients at Rehabilitation Facilities? McCants, K.C.
 2013
 32 4S p. S222-S223
2 p.
 artikel
559 Overexpression of IL-1 Receptor Antagonist Attenuates Obliterative Bronchiolitis in Murine Tracheal Transplant Model Sacher, V.Y.
 2013
 32 4S p. S104-
1 p.
 artikel
560 Oxidative Stress Induced DNA Damage and Repair in Heart Failure Patients Supported by Continuous Flow Ventricular Assist Devices Mondal, N.K.
 2013
 32 4S p. S178-
1 p.
 artikel
561 Palliative Care Referral and Outcomes in Lung Transplant Candidates Colman, R.E.
 2013
 32 4S p. S171-
1 p.
 artikel
562 Pathological Analysis of the Aortic Valve after Long-Term Mechanical Circulatory Support Hata, H.
 2013
 32 4S p. S279-
1 p.
 artikel
563 Pathological Substrates of Impaired Coronary Flow Reserve in Dilated Cardiomyopathy and Heart Transplant Patients Fedrigo, M.
 2013
 32 4S p. S163-
1 p.
 artikel
564 Pathologic Findings in Explanted Pulmonary Allografts Xu, L.
 2013
 32 4S p. S245-
1 p.
 artikel
565 Patient Directed Termination of Cardiac Mechanical Support: Is This Assisted Suicide? Suarez, E.E.
 2013
 32 4S p. S286-
1 p.
 artikel
566 Patients Expectations and Experiences of Rehabilitation after Lung Transplantation Fuller, L.M.
 2013
 32 4S p. S123-S124
2 p.
 artikel
567 Pattern and Predictors of Hospital Readmission after Lung Transplantation Zomak, R.
 2013
 32 4S p. S44-
1 p.
 artikel
568 Patterns of Acute Cellular Rejection the First Year after Heart Transplantation: A Single Center Retrospective Study at Skåne University Hospital in Lund 1988-2010 Söderlund, C.
 2013
 32 4S p. S260-
1 p.
 artikel
569 PDT Targeting Pulmonary Hypertension: Implications Prevention and Treatment by Photodynamic Therapy Zhao, Y.
 2013
 32 4S p. S301-
1 p.
 artikel
570 Pediatric Outpatient VAD Experience at Stanford Lin, A.
 2013
 32 4S p. S288-
1 p.
 artikel
571 Pediatric Thoracic Multiorgan Transplantation in the United States Khan, M.S.
 2013
 32 4S p. S151-
1 p.
 artikel
572 Pediatric Thymic Tissue as a Source of Regulatory T Cells for Cellular Therapy Dijke, E.
 2013
 32 4S p. S67-S68
2 p.
 artikel
573 Pediatric VAD Utilization in Dilated Cardiomyopathy: Does Higher VAD Utilization Lead to Better Waitlist Outcomes? Vander Pluym, C.J.
 2013
 32 4S p. S108-
1 p.
 artikel
574 Pediatric Ventricular Assist Device Use as a Bridge to Transplantation Does Not Affect Long-Term Quality of Life Ezon, D.S.
 2013
 32 4S p. S289-
1 p.
 artikel
575 Percutaneous Hemodynamic Support for Cardiogenic Shock Prior to Left Ventricular Assist Device Placement Shah, P.
 2013
 32 4S p. S141-
1 p.
 artikel
576 Perforation of the Pneumatic Driveline in Patients Converted to a Portable Driver for the Total Artificial Heart Shah, K.B.
 2013
 32 4S p. S54-
1 p.
 artikel
577 Perioperative Levosimendan Therapy Improves Renal Function in Heart Transplant Recipients Knezevic, I.
 2013
 32 4S p. S52-S53
2 p.
 artikel
578 Persisting Mild Lesions in Coronary Angiography Prognosticate Poor Long-Term Survival of Heart Transplant Recipients Zakliczynski, M.
 2013
 32 4S p. S211-
1 p.
 artikel
579 Pharmacologically Induced Hypothermia with WIN55,212-2 and Extracorporeal Life Support after Cardiac Arrest as a Preservation Strategy for Heart Transplantation Rungatscher, A.
 2013
 32 4S p. S121-S122
2 p.
 artikel
580 Physician and Parent Perceptions of End-of-Life Experience in Children with Advanced Heart Disease Morell, E.
 2013
 32 4S p. S10-
1 p.
 artikel
581 Pitfalls of ECMO Implementation in Lung Transplantation – A Survival Analysis Tomaszek, S.C.
 2013
 32 4S p. S218-
1 p.
 artikel
582 Plasma Adiponectin in Patients Pulmonary Arterial Hypertension Selimovic, N.
 2013
 32 4S p. S251-
1 p.
 artikel
583 Plasma Free Hemoglobin Potentiates the Association between Reperfusion FiO2 and Primary Graft Dysfunction after Lung Transplantation Ware, L.B.
 2013
 32 4S p. S42-S43
2 p.
 artikel
584 Plasma PAI-1 Used as a Quantitative Trait Implicates the Innate Immune Regulator TOLLIP in Post Lung Transplant Primary Graft Dysfunction Risk Cantu, E.
 2013
 32 4S p. S29-
1 p.
 artikel
585 Platelet GPIb Ectodomain Shedding – A New Biomarker for GI Bleeding in Continuous Flow VAD Recipients? Snyder, T.A.
 2013
 32 4S p. S71-
1 p.
 artikel
586 Population Pharmacokinetics and Bayesian Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients: Comparison of Two Approaches Youdarene, R.
 2013
 32 4S p. S111-
1 p.
 artikel
587 Post Discharge Non-Compliance Increases Risk of Left Ventricular Assist Device (LVAD) Malfunction but Does Not Affect Survival Hackmann, A.
 2013
 32 4S p. S176-
1 p.
 artikel
588 Post-Heart Transplant (HT) Survival for Adult Congenital Heart Disease (ACHD) Cheng, R.K.
 2013
 32 4S p. S206-
1 p.
 artikel
589 Post-Transcriptional Regulation of alpha-1-Antichymotrypsin by miR-137 in Chronic Heart Failure and Mechanical Support Lok, S.I.
 2013
 32 4S p. S96-S97
2 p.
 artikel
590 Potential Application of the CircuLite® Synergy® Circulatory Support System in the Treatment of Pulmonary Arterial Hypertension Meyns, B.
 2013
 32 4S p. S234-
1 p.
 artikel
591 Potential Role of XB130 in the Regulation of Airway Epithelium Repair and Regeneration after Transplantation Zhao, J.
 2013
 32 4S p. S296-
1 p.
 artikel
592 Prebypass Hemodynamic Instability in Patients with Severe Pulmonary Hypertension Undergoing Double Lung Transplantation Shah, P.
 2013
 32 4S p. S219-
1 p.
 artikel
593 Pre-Clinical Testing of Aerosolized Inhaled Milrinone Using a Vibrating Mesh Nebulizer Haglund, N.
 2013
 32 4S p. S252-S253
2 p.
 artikel
594 Predicting Lung Transplant Waitlist Survival with the Lung Allocation Score in British Columbia, Canada Hirji, A.
 2013
 32 4S p. S168-S169
2 p.
 artikel
595 Predicting Myocardial Recovery in Children with Dilated Cardiomyopathy West, S.C.
 2013
 32 4S p. S240-
1 p.
 artikel
596 Predicting Outcomes of Patients with Ventricular Assist Devices Who Suffer Neurological Injuries Ikeda, D.S.
 2013
 32 4S p. S278-
1 p.
 artikel
597 Predicting RV Failure after LVAD Implantation: Utility of Echocardiographic Strain and Defining RV Failure Link, C.B.
 2013
 32 4S p. S235-S236
2 p.
 artikel
598 Predictive Value of HLA Antibody Characteristics in Progression of Subclinical Antibody Mediated Rejection in Heart Transplant Recipients Askar, M.
 2013
 32 4S p. S87-
1 p.
 artikel
599 Predictive Value of Pulmonary Vascular Remodeling Indices after LVAD Implantation Okada, S.
 2013
 32 4S p. S230-
1 p.
 artikel
600 Predictive Value of Right Ventricular Function for Transplant-Free Survival with Pulmonary Arterial Hypertension Dandel, M.
 2013
 32 4S p. S77-S78
2 p.
 artikel
601 Predictors of Chronic Lung Allograft Dysfunction (CLAD) Following Respiratory Viral Infection (RVI) Halloran, K.
 2013
 32 4S p. S49-
1 p.
 artikel
602 Predictors of Mild Cognitive Dysfunction in an Advanced Heart Failure Population Chien, C.
 2013
 32 4S p. S166-
1 p.
 artikel
603 Predictors of Need of Renal Replacement Therapy among Lung Transplant Patients Admitted to the Medical Intensive Care Unit Banga, A.
 2013
 32 4S p. S264-S265
2 p.
 artikel
604 Predictors of Prolonged Status 1A Wait Time Prior to Heart Transplant Yang, J.A.
 2013
 32 4S p. S143-
1 p.
 artikel
605 Predisposition to Infection and Bleeding in Mechanical Assist Devices (LVADs) Recepients after Dental Procedures: A Single Center Experience McCants, K.C.
 2013
 32 4S p. S85-S86
2 p.
 artikel
606 Prednisolone as Preservation Additive Prevents from Ischemia Reperfusion Induced Graft Dysfunction in a Rat Model of Orthotopic Lung Transplantation Paulus, P.
 2013
 32 4S p. S152-S153
2 p.
 artikel
607 Pregnancy after Lung Transplantation: A Single Center Experience Thakrar, M.V.
 2013
 32 4S p. S61-
1 p.
 artikel
608 Pregnancy Outcomes in Female Heart Transplant Recipients with the Initial Diagnosis of Congenital Heart Defect Coscia, L.A.
 2013
 32 4S p. S129-
1 p.
 artikel
609 Pregnancy Outcomes in Heart Transplant Recipients with Exposure to Mycophenolic Acid Products Coscia, L.A.
 2013
 32 4S p. S39-
1 p.
 artikel
610 Preliminary Results: Both High and Low Literacy Lung Transplant Patients Have Difficulty Adhering to and Interpreting Home Spirometry Gries, C.J.
 2013
 32 4S p. S124-
1 p.
 artikel
611 Preoperative CHA2DS2-VASC Score Predicts Neurologic Complications in Continuous-Flow (CF) Left Ventricular-Assist Device (LVAD) Patients Sorensen, E.N.
 2013
 32 4S p. S72-
1 p.
 artikel
612 Preoperative Moderate to Severe Tricuspid Regurgitation Does Not Affect Outcomes Following Placement of Continuous Flow LVADs Robertson, J.O.
 2013
 32 4S p. S116-
1 p.
 artikel
613 Pre-Operative Velocity Vector Imaging To Predict the Need for Right Ventricular Support in Patients Undergoing Left Ventricular Assist Device Implantation Wang, L.
 2013
 32 4S p. S273-S274
2 p.
 artikel
614 Pressure and Flow Sequelae to Kinking of the HeartWare HVAD® Outflow Graft Connellan, M.
 2013
 32 4S p. S280-
1 p.
 artikel
615 Pre-Transplant Antibodies to Kα1Tubulin and Collagen V in Lung Transplantation: Correlation with Disease, Primary Graft Dysfunction, Donor Specific HLA Antibodies, and Chronic Rejection Tiriveedhi, V.
 2013
 32 4S p. S75-
1 p.
 artikel
616 Pre-Transplant Circulating Antibodies Predict Antibody-Mediated Rejection Using the New ISHLT Grading Scale Kittleson, M.
 2013
 32 4S p. S87-S88
2 p.
 artikel
617 Pre-Transplant Donor-Specific HLA Antibodies (DSA) Frequently Decline Following Lung Transplantation Baxter-Lowe, L.A.
 2013
 32 4S p. S171-
1 p.
 artikel
618 Prevalence and Clinical Correlates of Right Ventricular Dysfunction in Patients with Hypertrophic Cardiomyopathy Finocchiaro, G.
 2013
 32 4S p. S21-S22
2 p.
 artikel
619 Prevalence and Prognostic Importance of Changes in Renal Function Following Mechanical Circulatory Support Brisco, M.A.
 2013
 32 4S p. S72-
1 p.
 artikel
620 Prevalence and Severity of Diverticular Disease in the Post-Lung Transplant Population – A Single Center’s Experience Thomas, L.K.
 2013
 32 4S p. S268-
1 p.
 artikel
621 Prevalence of Psychological Distress and Stress Moderators in UK Transplant Candidates: Malpus, Z.G.
 2013
 32 4S p. S127-
1 p.
 artikel
622 Prevalence of Thrombophilia and Thrombogenic Factors among 122 Heart Transplant Recipients Salmela, B.
 2013
 32 4S p. S205-
1 p.
 artikel
623 Prevention of Resistant CMV Infection Using Persistent Valganciclovir Therapy through Leukopenia and Extending the Duration Wadhwa, A.
 2013
 32 4S p. S129-S130
2 p.
 artikel
624 Primary Graft Dysfunction Following Heart Transplantation; Validity of a Pragmatic Self-Reporting Definition Dronavalli, V.B.
 2013
 32 4S p. S213-S214
2 p.
 artikel
625 Primary Graft Dysfunction Mimic – Pulmonary Vein Thrombosis in the Postoperative Lung Transplant Patient Kaleekal, T.
 2013
 32 4S p. S269-
1 p.
 artikel
626 Primary Graft Dysfunction vs. Primary Graft Failure: Are All Graft Problems Created Equal? Aliabadi, A.Z.
 2013
 32 4S p. S212-S213
2 p.
 artikel
627 Primary Graft Failure after Heart Transplantation: Risk Factors Analysis and Long Term Results Marco, R.
 2013
 32 4S p. S260-
1 p.
 artikel
628 Prognostic Implications of Donor Age in Outcomes of Heart Transplantation Mirabet, S.
 2013
 32 4S p. S53-
1 p.
 artikel
629 Pro-Inflammatory HDL Result from Altered HDL Oxidized Lipid Mediators in Both Idiopathic and Associated Types of Pulmonary Arterial Hypertension Ross, D.J.
 2013
 32 4S p. S302-
1 p.
 artikel
630 Prolactin – A New Marker for ECMO-Related Mortality Neumann, A.
 2013
 32 4S p. S225-
1 p.
 artikel
631 Proliferation Signal Inhibitors Reduce Severity of Cardiac Allograft Vasculopathy after Heart Transplantation Patel, J.
 2013
 32 4S p. S50-
1 p.
 artikel
632 Prolonged Mechanical Circulatory Support – 1000 Days with a Left Ventricular Assist Device Oezpeker, C.
 2013
 32 4S p. S285-
1 p.
 artikel
633 Prolonged Mechanical Ventilation in Lung Transplant Recipients: Predictive Factors and Outcomes Gomez, C.
 2013
 32 4S p. S270-
1 p.
 artikel
634 Promising Outcomes after Long-Term Therapy with Everolimus: Two-Years Results of the CERTIC Registry Potena, L.
 2013
 32 4S p. S199-S200
2 p.
 artikel
635 Proposal for Advanced Life Support Algorithm in Unresponsive Hospitalized LVAD Patients Yuzefpolskaya, M.
 2013
 32 4S p. S284-
1 p.
 artikel
636 PROSPECT Patient Subgroups and Etiologies: Predictors of Outcomes Schilz, R.O.
 2013
 32 4S p. S17-
1 p.
 artikel
637 Proteasome Inhibitor Therapy for Antibody-Mediated Lung Transplant Rejection Iuppa, J.A.
 2013
 32 4S p. S89-S90
2 p.
 artikel
638 Protective Effect of Plasmin in Marginal Donor Lungs in an Ex Vivo Lung Perfusion Model Motoyama, H.
 2013
 32 4S p. S247-
1 p.
 artikel
639 Protein Expression Profiling Predicts Graft Performance in Clinical Ex Vivo Lung Perfusion Machuca, T.N.
 2013
 32 4S p. S47-
1 p.
 artikel
640 Psychiatric Diagnoses and the Use of Psychiatric Medication in Pediatric Ventricular Assist Device Recipients Lefkowitz, D.S.
 2013
 32 4S p. S288-
1 p.
 artikel
641 Psychosocial Risk as a Predictor of Survival Following LVAD Implant Akhter, S.A.
 2013
 32 4S p. S132-
1 p.
 artikel
642 Pulmonary Arterial Bed Reperfusion Induces Regression of Distal Vasculopathy in a Chronic Thromboembolic Pulmonary Hypertension Piglet Model Boulate, D.
 2013
 32 4S p. S305-
1 p.
 artikel
643 Pulmonary Edema and Biomarkers of Inflammation and Lung Epithelial Dysfunction Are Associated with Donor Smoking in the Ex Vivo Donor Lung Ware, L.B.
 2013
 32 4S p. S152-
1 p.
 artikel
644 Pulmonary Endarterectomy in Patients with Borderline Pulmonary Hypertension Berman, M.
 2013
 32 4S p. S303-S304
2 p.
 artikel
645 Pulmonary Hypertension Associated to Sarcoidosis: Data from the Swiss PH Registry Verdi, G.
 2013
 32 4S p. S303-
1 p.
 artikel
646 Pulmonary Hypertension Following Maze Surgery for Atrial Fibrillation Hardegree, E.L.
 2013
 32 4S p. S302-S303
2 p.
 artikel
647 Pulmonary Hypertension in End-Stage Pulmonary Fibrosis: Prevalence, Predictors and Survival before and after Lung Transplantation Bjurström, L.
 2013
 32 4S p. S18-S19
2 p.
 artikel
648 Pulmonary Venous Hypertension in End-Stage COPD and Preserved Systolic Left Ventricular Function: Vascular Lesions in Explanted Lungs after Transplantation Andersen, K.H.
 2013
 32 4S p. S62-S63
2 p.
 artikel
649 Pus Bonum Et Laudabile? – Wound Healing Complications after Heart Transplantation in the 21st Century Groemmer, M.
 2013
 32 4S p. S257-
1 p.
 artikel
650 QRS and QT Interval Changes and Ventricular Arrhythmias Following Continuous Flow Mechanical Unloading of the Failing Human Heart Saidi, A.
 2013
 32 4S p. S232-
1 p.
 artikel
651 Quality of Life of Children with Pulmonary Hypertension Wray, J.
 2013
 32 4S p. S64-
1 p.
 artikel
652 Quantification of Circulating Donor Specific Cell Free DNA Is an Exquisitely Sensitive Non-Invasive Indicator of Injury to the Donor Heart Hidestrand, P.
 2013
 32 4S p. S101-S102
2 p.
 artikel
653 Quantification of Lipid Burden in Heart Transplant (HT) Patients by Near-Infrared Spectroscopy (NIRS) Cheng, R.K.
 2013
 32 4S p. S209-
1 p.
 artikel
654 Quantifying the Cardiorenal Syndrome and Its Effect on Mortality after LVAD Implant: An Analysis of 4,917 Patients from INTERMACS Kirklin, J.K.
 2013
 32 4S p. S133-
1 p.
 artikel
655 Quantitative Three Dimensional Echocardiographic Assessment of the Right Ventricle Can Identify Risk of Right Ventricular Failure in Patients Undergoing Left Ventricular Assist Device Surgery French, A.L.
 2013
 32 4S p. S226-S227
2 p.
 artikel
656 Quilty Revisited: Association with pAMR and Worse Outcomes Post Heart Transplantation Revelo, M.P.
 2013
 32 4S p. S101-
1 p.
 artikel
657 Racial Differences in over 1000 Patients with Continuous Flow Left Ventricular Assist Devices Bhat, G.
 2013
 32 4S p. S178-
1 p.
 artikel
658 Racial Disparities after Heart Transplant: Evidence from IMAGE Khush, K.K.
 2013
 32 4S p. S102-S103
2 p.
 artikel
659 Racial Disparities in Patients Bridged to Heart Transplantation with a Ventricular Assist Device Beaty, C.A.
 2013
 32 4S p. S112-S113
2 p.
 artikel
660 Radiation Exposure and Attribute Cancer Risk after Lung Transplantation Rosengarten, D.
 2013
 32 4S p. S267-
1 p.
 artikel
661 Radionuclide Angiographic Assessment of Right Ventricular Ejection Fraction Is Pronostic in Pulmonary Arterial Hypertension Courand, P.-Y.
 2013
 32 4S p. S105-
1 p.
 artikel
662 Rapid Respiratory Failure after Heart Transplant Mani, B.
 2013
 32 4S p. S139-S140
2 p.
 artikel
663 Rapid Tolerance Induction for Solid Organ Transplantation by Myeloid Progenitor Cells Domen, J.
 2013
 32 4S p. S246-
1 p.
 artikel
664 Reasons for Left Ventricular Assist Device Patient Denial: Insights into Possible Misconceptions about Mechanical Circulatory Support McCandless, S.P.
 2013
 32 4S p. S99-S100
2 p.
 artikel
665 Recipient Cytokine Levels Are Associated with Primary Cardiac Allograft Failure Ishida, M.
 2013
 32 4S p. S258-
1 p.
 artikel
666 Reduced HLA Class II Antibody Response to Proteasome Inhibition Khuu, T.
 2013
 32 4S p. S114-
1 p.
 artikel
667 Reduction of Obliterative Bronchiolitis (OB) by Prolyl-Hydroxylase-Inhibitors Activating Hypoxia-Inducible Transcription Factors in an Experimental Mouse Model Heim, C.
 2013
 32 4S p. S296-
1 p.
 artikel
668 Refinement of Perioperative Management in Lung Transplantation in Patients with Pulmonary Hypertension: A Single Center Experience Nierlich, P.
 2013
 32 4S p. S301-
1 p.
 artikel
669 Regional Structural Uniformity of Left Ventricular Remodeling in Patients with Advanced Non Ischemic Cardiomyopathy Passi, S.F.
 2013
 32 4S p. S277-
1 p.
 artikel
670 Regression of Inflammation in the Failing Human Heart after Continuous Flow Left Ventricular Assist Device-Induced Mechanical Unloading? Diakos, N.A.
 2013
 32 4S p. S184-
1 p.
 artikel
671 Regulatory T Cells (Tregs) in Neonatal Tolerance: Allogeneic Tregs Regulate the Neonatal Immune System and Prolong Heart Graft Survival Bascom, R.A.
 2013
 32 4S p. S297-
1 p.
 artikel
672 Renal Dysfunction Does Not Contraindicate Ventricular Assist Device as Destination Therapy or as Bridge to Single Heart or Combined Heart and Kidney Transplantation Ruzza, A.
 2013
 32 4S p. S231-
1 p.
 artikel
673 Renal Replacement Therapy in Patients Undergoing Continuous-Flow Left Ventricular Assist Devices (LVADs) Alsaied, O.
 2013
 32 4S p. S276-
1 p.
 artikel
674 Renin-Angiotensin System (RAS) Blockade Reduces Proteinuria in Heart Transplant Recipients: An Observational, Longitudinal Analysis Shakowski, C.K.
 2013
 32 4S p. S262-
1 p.
 artikel
675 Restrictive Allograft Syndrome CT Findings Are a Recent Feature of Chronic Lund Allograft Dysfunction Gamondes, D.
 2013
 32 4S p. S221-
1 p.
 artikel
676 Results of a Randomized Trial of Allomap vs Heart Biopsy in the 1st Year after Heart Transplant: Early Invasive Monitoring Attenuation through Gene Expression Trial Kobashigawa, J.
 2013
 32 4S p. S203-
1 p.
 artikel
677 Results of the Registry To EValuate the HeartWare Left Ventricular Assist System (The REVOLVE Registry) Strueber, M.
 2013
 32 4S p. S11-
1 p.
 artikel
678 Resveratrol Attenuates Stimulated T-Cells Activation and Proliferation: A Novel Therapy Against Cellular Rejection in Cardiac Transplantation Nagendran, J.
 2013
 32 4S p. S248-S249
2 p.
 artikel
679 Retrograde Machine Perfusion for Long-Term Preservation of Canine Hearts Cobert, M.L.
 2013
 32 4S p. S155-S156
2 p.
 artikel
680 Retrospective Review of PRES in Lung Transplantation Allred, A.M.
 2013
 32 4S p. S271-
1 p.
 artikel
681 Return to Work after Heart Transplantation: The New Zealand Experience Samaranayake, C.B.
 2013
 32 4S p. S198-
1 p.
 artikel
682 REVEAL Model Simplified: Performance of the REVEAL Pulmonary Arterial Hypertension Prediction Model Using-Non Invasive and Routinely Measured Parameters Cogswell, R.J.
 2013
 32 4S p. S17-
1 p.
 artikel
683 Rhinovirus Infection in Adult Lung Transplant Recipients: A Case-Controlled Study Vandervest, K.M.
 2013
 32 4S p. S188-
1 p.
 artikel
684 Right Atrial to Pulmonary Capillary Wedge Pressure Ratio Is Not Associated with Failure of Optimal Medical Management in the INTERMACS 4-5 Population Menachem, J.N.
 2013
 32 4S p. S22-
1 p.
 artikel
685 Right Ventricular Distension in Donor Hearts Following Cardiocirculatory Death: Implications for Post-Transplant Function White, C.W.
 2013
 32 4S p. S95-
1 p.
 artikel
686 Right Ventricular Dyssynchrony Predicts Clinical Worsening in Idiopathic Pulmonary Arterial Hypertension Badagliacca, R.
 2013
 32 4S p. S79-
1 p.
 artikel
687 Right Ventricular Failure Following Left Ventricular Assist Device Implantatation; the Myth Is in the Management Eleuteri, K.L.
 2013
 32 4S p. S280-
1 p.
 artikel
688 Right Ventricular Outflow Tract Velocity Time Integral Is the Strongest Echo-Doppler Predictor of Right Ventricular Fibrosis in Patients with Pulmonary Arterial Hypertension Soma, S.K.R.
 2013
 32 4S p. S106-S107
2 p.
 artikel
689 Right Ventricular Support for Pulmonary Arterial Hypertension: An Acute Feasibility Study in Sheep Verbelen, T.
 2013
 32 4S p. S78-S79
2 p.
 artikel
690 Right Ventricular Systolic Strain Predicts Outcomes in Pulmonary Hypertension: A Prospective Evaluation Fine, N.M.
 2013
 32 4S p. S77-
1 p.
 artikel
691 Rising NT-proBNP Is More Reflective of an Enlarging Right Ventricle Than of Changing RVEF in PAH Hamadah, A.
 2013
 32 4S p. S302-
1 p.
 artikel
692 Risk Factors and Response to Therapy in Heart and Lung Transplant Recipients with Post-Transplant Lymphoproliferative Disease Kumarasinghe, G.
 2013
 32 4S p. S254-
1 p.
 artikel
693 Risk Factors for the Development of Late Pulmonary Complications Following Pediatric Heart Transplant Steinfeld, T.
 2013
 32 4S p. S238-
1 p.
 artikel
694 Risk Factors of Death for Patients with UNOS 2 Status Listed for OHT Zielinski, T.
 2013
 32 4S p. S144-S145
2 p.
 artikel
695 Risk Factors of Renal Dysfunction Following Cardiac Transplantation Lachance, K.
 2013
 32 4S p. S258-
1 p.
 artikel
696 Risk Prediction Models for Mortality in Ambulatory Heart Failure Patients: A Systematic Review Alba, A.C.
 2013
 32 4S p. S164-
1 p.
 artikel
697 RNA Sequencing Identifies Novel Genes That Could Modulate Bleeding Risk in Heart Failure Patients after LVAD Placement Mitchell, A.
 2013
 32 4S p. S148-
1 p.
 artikel
698 Role of Angiogenesis in the Right Ventricle Remodeling in Response to Pulmonary Hypertension Noly, P.E.
 2013
 32 4S p. S78-
1 p.
 artikel
699 Role of Donor-Recipient Match in Determining the Risk for Primary Graft Failure after Heart Transplantation Lonetti, C.
 2013
 32 4S p. S255-S256
2 p.
 artikel
700 Role of HLA-G Expression as a Predictive Marker of a Low Risk of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients: A 3-Year Prospective Study Brugière, O.
 2013
 32 4S p. S168-
1 p.
 artikel
701 Role of Percutaneous Intervention in Treatment of Proximal Cardiac Allograft Vasculopathy as Compared to Diffuse Distal Disease Agarwal, S.
 2013
 32 4S p. S50-S51
2 p.
 artikel
702 Routine Delayed Sternal Closure after Left Ventricular Assist Device Implantation with Vacuum Assisted Device Yanagida, R.
 2013
 32 4S p. S281-
1 p.
 artikel
703 Safety and Effectiveness of Exercise Training in Patients with Continuous Flow Ventricular Assist Devices Moscato, F.
 2013
 32 4S p. S181-
1 p.
 artikel
704 Safety and Feasibility of Surgical AF Ablation in Patients with Severely Reduced Left Ventricular Ejection Fraction (LVEF) Pecha, S.
 2013
 32 4S p. S161-
1 p.
 artikel
705 Safety of a Mesenchymal-Like Adherent Stromal Cell (PLX-PAD) in a Human Model of Pulmonary Arterial Hypertension (PAH) Chambers, D.C.
 2013
 32 4S p. S65-S66
2 p.
 artikel
706 Safety of Early Everolimus in De Novo Heart Transplant Recipients: Interim Analysis of the Randomized Study EVERHEART Potena, L.
 2013
 32 4S p. S136-
1 p.
 artikel
707 Scandinavian Heart Transplant Everolimus De Novo Study with Early Calcineurin Inhibitor Avoidance (SCHEDULE) Andreassen, A.K.
 2013
 32 4S p. S134-
1 p.
 artikel
708 School Re-Integration for Pediatric VADs Lin, A.
 2013
 32 4S p. S195-
1 p.
 artikel
709 Screening Patients with Cardiac Resynchronization Therapy/Implantable Cardioverter-Defibrillator for Indications for Heart Transplantation and Left Ventricular Assist Device: A Pilot Study Zabarovskaja, S.
 2013
 32 4S p. S161-
1 p.
 artikel
710 Serum Amyloid A (SAA) Is a Sensitive Surrogate Marker for IL-6R Blockage by Therapeutic IL6R Antibody: A Study in a Mouse Model of Allosensitization Wu, G.
 2013
 32 4S p. S300-S301
2 p.
 artikel
711 Severity of End Organ Damage as a Predictor of Outcomes after Implantation of Continuous Flow Left Ventricular Assist Devices (LVAD) Landis, Z.C.
 2013
 32 4S p. S222-
1 p.
 artikel
712 S100 Family Proteins in Human Chronic Lung Allograft Dysfunction: Potential Markers for Biologic Subtyping Saito, T.
 2013
 32 4S p. S60-
1 p.
 artikel
713 Should Recipients Choose Their Donor? Experience of a New Consent Process in Lung Transplantation Morley, K.E.
 2013
 32 4S p. S43-S44
2 p.
 artikel
714 Significance of Persistent EBV Viral Load in Pediatric Heart Transplant Recipients Das, B.B.
 2013
 32 4S p. S256-
1 p.
 artikel
715 Sildenafil Improves Small Artery Elasticity in Heart Transplant Recipients Colvin-Adams, M.M.
 2013
 32 4S p. S207-
1 p.
 artikel
716 Sildenafil in LVAD Is Safe and Well Tolerated Ravichandran, A.
 2013
 32 4S p. S294-
1 p.
 artikel
717 Single Lung Transplantation Using Donors with Heavy Smoking History Can Be Safely Performed Taghavi, S.
 2013
 32 4S p. S154-S155
2 p.
 artikel
718 SLCO1B1 Genotype Influences the Drug-Drug Interaction between Cyclosporine and Pravastatin Aquilante, C.L.
 2013
 32 4S p. S292-S293
2 p.
 artikel
719 Slight Exercise in Ambulatory LVAD Patients Leads to a Severe Compromise of Hemodynamic Parameters Camboni, D.
 2013
 32 4S p. S92-
1 p.
 artikel
720 Socioeconomic Disparities Associated with Medication Non-Adherence Following Lung Transplantation in Adult Recipients Castleberry, A.W.
 2013
 32 4S p. S44-S45
2 p.
 artikel
721 Specific Therapy Modulate Circulating Levels of Adiponectin in Patients with Pulmonary Arterial Hypertension Selimovic, N.
 2013
 32 4S p. S251-
1 p.
 artikel
722 Static Cold Storage of Brain Dead Donor Hearts: Can ‘Pharmacological Conditioning’ Overcome Primary Graft Failure? Kumarasinghe, G.
 2013
 32 4S p. S158-S159
2 p.
 artikel
723 Statin Therapy after Pediatric Heart Transplantation Is Safe, Effective and Protects Against Rejection and PTLD Greenway, S.C.
 2013
 32 4S p. S239-
1 p.
 artikel
724 Stress and Anxiety in Caregivers of Lung Transplant Patients: Effect of Mindfulness Based Stress Reduction Haines, J.
 2013
 32 4S p. S45-
1 p.
 artikel
725 Structured Rehabilitation Program in LVAD Patients Leads to Shortened Lengths of Stay Bunge, R.R.
 2013
 32 4S p. S175-
1 p.
 artikel
726 Sub-Acute Animal Implantation of a Novel Bioprosthethic Artificial Heart Latremouille, C.
 2013
 32 4S p. S174-S175
2 p.
 artikel
727 Subcostal LVAD Exchange Is Associated with Shorter Recovery and Improved Long Term Survival Than Full Sternotomy Approach Itoh, A.
 2013
 32 4S p. S187-
1 p.
 artikel
728 Substantial Recovery of Renal Function Is Uncommon Early Post Cardiac Transplant Irrespective of Pre-Transplant LVAD Support Brisco, M.A.
 2013
 32 4S p. S272-
1 p.
 artikel
729 Successful Extracorporeal Membrane Oxygenation Support Following Pulmonary Endarterectomy Berman, M.
 2013
 32 4S p. S18-
1 p.
 artikel
730 Suppression of Spleen Tyrosine Kinase Attenuated Obliterative Bronchiolitis Associated Lymphoid Neogenesis after Lung Transplantation Matsuda, Y.
 2013
 32 4S p. S220-
1 p.
 artikel
731 Surfactant Pretreatment Is Superior to Treatment after Reperfusion for Lung Ischemia-Reperfusion Injury van der Kaaij, N.P.
 2013
 32 4S p. S42-
1 p.
 artikel
732 Survival after Heart Retransplantation Colvin-Adams, M.
 2013
 32 4S p. S13-
1 p.
 artikel
733 Survival after Lung Transplantation Is Linked with a Genetic Polymorphism in Caveolin-1 Vandermeulen, E.
 2013
 32 4S p. S120-S121
2 p.
 artikel
734 Survival Benefit of Lung Transplantation in Japan: Extreme Donor Shortage and the Potential Role of Living Transplantation Sato, M.
 2013
 32 4S p. S172-
1 p.
 artikel
735 Survival in Pulmonary Arterial Hypertension Patients Awaiting Transplant Gomberg-Maitland, M.
 2013
 32 4S p. S140-
1 p.
 artikel
736 Sympathetic Reinnervation of the Sinus Node Following Cardiac Transplantation: Time-Course and Prevalence Das, M.
 2013
 32 4S p. S204-
1 p.
 artikel
737 Systemic Analysis of Metabolic Products and Related Gene Expression in Human Lung of Pulmonary Arterial Hypertension Using Ultrahigh Performance Liquid Chromatography and Microarray Zhao, Y.
 2013
 32 4S p. S305-
1 p.
 artikel
738 Systemic Inhibition of Angiopoietin-2 Prevents Endothelial Activation, and Acute Rejection in Rat Cardiac Allografts Syrjälä, S.O.
 2013
 32 4S p. S136-
1 p.
 artikel
739 Tacrolimus Causes Airway Mucociliary Clearance Impairment Silva, M.P.
 2013
 32 4S p. S249-
1 p.
 artikel
740 Tacrolimus Level Variability Is a Novel Measure Associated with Increased Acute Rejection in Lung Transplant (LTx) Recipients Chiang, C.Y.
 2013
 32 4S p. S170-
1 p.
 artikel
741 Tacrolimus- Versus Cyclosporine-Induced Diabetes Leads to More Diabetic Complications after Heart Transplantation Velleca, A.
 2013
 32 4S p. S202-
1 p.
 artikel
742 Targeting Anti-Oxidant and Anti-Proliferative Pathways in Pulmonary Hypertension Secondary to Heart Failure. Is One Better Than the Other? Ravi, Y.
 2013
 32 4S p. S304-S305
2 p.
 artikel
743 Targeting Steroid Resistant Peripheral Blood Pro-Inflammatory CD28null T Cells by Inhibiting CD137 Expression: Relevance to BOS Hodge, G.
 2013
 32 4S p. S246-
1 p.
 artikel
744 T Cell-Deficiency Exacerbates Diacetyl-Induced Obliterative Bronchiolitis Martinu, T.
 2013
 32 4S p. S81-
1 p.
 artikel
745 T Cell Responses in Lung Transplantion – Role of Alloantigen Priming and Regulation on Development of Transplant Arteriosclerosis in a Humanized Mouse Model Knöfel, A.-K.
 2013
 32 4S p. S245-S246
2 p.
 artikel
746 Temporary Mechanical Circulatory Support for Acute Right Ventricular Failure Cheung, A.
 2013
 32 4S p. S177-
1 p.
 artikel
747 Temporary RVAD Support after LVAD – Longterm Outcome Oezpeker, C.C.O.
 2013
 32 4S p. S285-
1 p.
 artikel
748 The Activation of mTOR Pathway in Endothelial Cells Correlates with Antibody-Mediated Rejection (AMR) in Endomyocardial Biopsies (EMB) Tible, M.
 2013
 32 4S p. S20-
1 p.
 artikel
749 The Added Value of Exercise Variables in Addition to Clinical Predictors To Predict Prognosis in Heart Failure Adamson, M.W.
 2013
 32 4S p. S112-
1 p.
 artikel
750 The CCL2/CCR2 Axis in Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome Following Lung Transplantation Der Hovanessian, A.
 2013
 32 4S p. S28-S29
2 p.
 artikel
751 The Characteristics and Outcomes of Advanced Heart Failure Patients with Hemodynamic Parameters Predictive of Right Ventricular Failure Mentz, R.J.
 2013
 32 4S p. S119-
1 p.
 artikel
752 The Clinical Impact of Ventricular Arrhythmias Following Continuous Flow Left Ventricular Assist Device Implantation Garan, A.R.
 2013
 32 4S p. S173-
1 p.
 artikel
753 The Clinical Inaccuracy of Estimated Flow in Continuous Flow Ventricular Assist Devices Thenappan, T.
 2013
 32 4S p. S180-S181
2 p.
 artikel
754 The CYP3A Enzyme Inhibitor Diltiazem, Rather Than Genetic Polymorphisms, Is Associated with Everolimus Concentrations in Lung Transplant Recipients Schoeppler, K.E.
 2013
 32 4S p. S295-S296
2 p.
 artikel
755 The Development and Impact of De Novo Circulating Antibodies in Non-Sensitized Patients after Heart Transplantation Patel, J.
 2013
 32 4S p. S86-
1 p.
 artikel
756 The Development of Clostridium Difficile in Heart Transplant Patients on Different Immunosuppression Regimens Kittleson, M.
 2013
 32 4S p. S131-
1 p.
 artikel
757 The Downtime Donor Heart: Analysis of Pre-Transplant Function and Current Utilization for Transplantation Ali, A.A.
 2013
 32 4S p. S159-
1 p.
 artikel
758 The Effect of Achromobacter xylosidans in Adult Cystic Fibrosis Lung Transplant Recipients Rendulic, T.
 2013
 32 4S p. S131-
1 p.
 artikel
759 The Effect of Continuous Flow Left Ventricular Assist Device (CF-LVAD) Implantation on Serum Uric Acid Levels Rosenbaum, A.N.
 2013
 32 4S p. S274-S275
2 p.
 artikel
760 The Effect of Nutritional Status on Heart Transplant Survival in Patients under Two Years of Age Godown, J.
 2013
 32 4S p. S128-
1 p.
 artikel
761 The Effect of Percuatneous Lead Placement on Drive Line Exit Site Infections in HeartMate II Patients Perry, W.H.
 2013
 32 4S p. S181-S182
2 p.
 artikel
762 The Experience of Heart Transplant as a Young Adult Waldron, R.
 2013
 32 4S p. S196-
1 p.
 artikel
763 The Fate of Atrioventricular Valve Function of Transplanted Heart Kim, G.S.
 2013
 32 4S p. S207-
1 p.
 artikel
764 The Gradient between Diastolic Pulmonary Arterial Pressure and Pulmonary Wedge Pressure Is Important in the Evaluation of Post-Capillary Pulmonary Hypertension Stettler, S.
 2013
 32 4S p. S252-
1 p.
 artikel
765 The HeartWare Transvalvular Miniature Ventricular Assist Device Used for Right Ventricular Support Connellan, M.
 2013
 32 4S p. S149-
1 p.
 artikel
766 The Hemodynamic Effects of the MEGA Intra-Aortic Balloon Counterpulsation Pump Majithia, A.
 2013
 32 4S p. S226-
1 p.
 artikel
767 The Impact of Donor Benign Intimal Thickening on Cardiac Allograft Vasculopathy Devitt, J.J.
 2013
 32 4S p. S208-
1 p.
 artikel
768 The Impact of Donor Renal Function on Cardiac Allograft Survival: Insights into Reno-Cardiac Interactions Brisco, M.A.
 2013
 32 4S p. S253-
1 p.
 artikel
769 The Impact of Heart Transplant on Adolescent Siblings Martin, K.
 2013
 32 4S p. S195-
1 p.
 artikel
770 The Impact of Repeat HLA Mismatches on the Development of De Novo Donor Specific HLA Antbodies (DSA) in Lung ReTransplants Askar, M.
 2013
 32 4S p. S172-
1 p.
 artikel
771 The Impact of Severe Pulmonary Arterial Hypertension on Single Lung Transplantation in Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis: An Analysis of the UNOS Database Kon, Z.N.
 2013
 32 4S p. S120-
1 p.
 artikel
772 The Importance of Repeated Measurements To Assess Transplant Suitability in Clinical Ex Vivo Lung Perfusion (EVLP) Slama, A.
 2013
 32 4S p. S123-
1 p.
 artikel
773 The Incidence of Circulating Antibodies at the Time of Pathology Defined Antibody-Mediated Rejection after Heart Transplantation Patel, J.
 2013
 32 4S p. S20-S21
2 p.
 artikel
774 The INSPIRE International Lung Trial with the Organ Care System Technology (OCS™) Warnecke, G.
 2013
 32 4S p. S16-
1 p.
 artikel
775 The Lung Microbiome and Development of Bronchiolitis Obliterans Syndrome after Pediatric Lung Transplantation Sagar, M.
 2013
 32 4S p. S151-
1 p.
 artikel
776 The Obesity Paradox Stimpson, E.
 2013
 32 4S p. S212-
1 p.
 artikel
777 The Positive Impact of Pre-Operative VAD Education in the Reduction of Hospital Length of Stay Meehan, K.A.
 2013
 32 4S p. S236-
1 p.
 artikel
778 The Prevalence of Aortic Insufficiency in Patients Maintained on Continuous Flow Left Ventricular Assist Devices Bejar, D.
 2013
 32 4S p. S185-
1 p.
 artikel
779 The PROCEED II International Heart Transplant Trial with the Organ Care System Technology (OCS) Esmailian, F.
 2013
 32 4S p. S95-S96
2 p.
 artikel
780 Therapeutic Peptide-Modified Gold Nanoparticles for the Treatment of Acute Lung Injury Lee, D.
 2013
 32 4S p. S109-
1 p.
 artikel
781 The Ratio of Epidermal Growth Factor (EGF) to Monocyte Chemotactic Peptide-1 (MCP1) in the Urine May Predict Renal Prognosis in HTx Fiocchi, R.
 2013
 32 4S p. S211-S212
2 p.
 artikel
782 The Regulatory Capacity of Interleukin-10 Producing B Cells and Their Possible Role on Graft Acceptance in Children Ling, Y.
 2013
 32 4S p. S150-
1 p.
 artikel
783 The Relationship of Pulmonary Vascular Resistance and Pulmonary Arterial Compliance with Right Ventricular Function in Pulmonary Arterial Hypertension Sudini, N.L.
 2013
 32 4S p. S63-S64
2 p.
 artikel
784 The Role of Echocardiography in Patients with Intravascular Hemolysis Due to Suspected Continuous-Flow Left Ventricular Assist Device Thrombus Fine, N.M.
 2013
 32 4S p. S117-
1 p.
 artikel
785 The Role of Human Umbilical Cord Mesenchymal Sterm Cells in Attenuating Ischemia-Reperfusion Injury in Rat Lung Transplantation Model Mao, W.
 2013
 32 4S p. S248-
1 p.
 artikel
786 The Selective JAK1/3 Inhibitor R507 Prevents Acute Rejection and Chronic Obliteration of Transplanted Rat Tracheas Deuse, T.
 2013
 32 4S p. S82-
1 p.
 artikel
787 The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): A New Scale for the Prediction of Psychosocial and Medical Outcomes in Organ Transplant Candidates Maldonado, J.R.
 2013
 32 4S p. S79-S80
2 p.
 artikel
788 The SysCLAD- Systems Prediction of Chronic Lung Allograft Dysfunction Study: Aims, Strategy and First Data Pison, C.
 2013
 32 4S p. S220-
1 p.
 artikel
789 The United States Heart and Lung Transplant “Social” Network. Insights from the UNOS Database Venugopal, S.
 2013
 32 4S p. S159-S160
2 p.
 artikel
790 The Use of the Impella Device in Patients with Postcardiotomy Cardiogenic Shock Lemaire, A.
 2013
 32 4S p. S283-
1 p.
 artikel
791 The Utility of Pyscho-Social Assessment Tools in Predicting Cardiovascular Outcomes in Post Cardiac Transplant Patients Sharma, N.C.
 2013
 32 4S p. S197-
1 p.
 artikel
792 The Utility of 320 Row Multi-Detector Computed Tomography in Evaluating Patients with Left Ventricular Assist Devices Chrysant, G.S.
 2013
 32 4S p. S183-
1 p.
 artikel
793 The Utility of Speckle Tracking Echocardiography (STE) Derived Strain for the Detection of Acute Rejection after Pediatric Heart Transplantation Jeewa, A.
 2013
 32 4S p. S190-S191
2 p.
 artikel
794 The Value of Cardiorenal Biomarkers for Prediction of Renal Dysfunction after Heart Transplantation Hoskova, L.
 2013
 32 4S p. S205-
1 p.
 artikel
795 The Value of Pump Audiosignals in Patients with Left Ventricular Assist Devices Markey, P.
 2013
 32 4S p. S30-
1 p.
 artikel
796 The Virtual Crossmatch at Children’s Hospital of Wisconsin – Outcomes for Predicted Positive Crossmatches Zangwill, S.
 2013
 32 4S p. S115-
1 p.
 artikel
797 The Worldwide Use of SynCardia Total Artificial Heart in Patients with Congenital Heart Disease Morales, D.L.
 2013
 32 4S p. S142-
1 p.
 artikel
798 Three Center Experience with Clinical Normothermic Ex Vivo Lung Perfusion Cypel, M.
 2013
 32 4S p. S16-
1 p.
 artikel
799 Thrombin Generation and Platelet Activation in a Xenogenic Lung Perfusion Model Determine Survival of GalTKO.hCD46 Lungs Burdorf, L.
 2013
 32 4S p. S137-S138
2 p.
 artikel
800 Thrombocytosis More Common in Acute Rejection or Infection in the First 30 Days Post Lung Transplantation Catlyn, K.F.
 2013
 32 4S p. S270-
1 p.
 artikel
801 Thrombosis and Bleeding Complications in Pediatric Patients with Ventricular Assist Devices Conway, J.
 2013
 32 4S p. S290-
1 p.
 artikel
802 Thrombotic Complications Increase after Percutaneous Site/Pocket Infection in Patients with Left Ventricular Assist Devices: An INTERMACS Analysis Shah, M.R.
 2013
 32 4S p. S84-S85
2 p.
 artikel
803 Time after Lung Transplantation Influence the Correlation between Acute Rejection and Frequency of Regulatory T Cells in Transbronchial Lung Biopsies Krustrup, D.
 2013
 32 4S p. S216-
1 p.
 artikel
804 Time from Development of De Novo Donor-Specific HLA Antibodies to Rejection or Graft Loss in Pediatric Cardiac Transplantation Irving, C.
 2013
 32 4S p. S149-S150
2 p.
 artikel
805 Time To Reach Therapeutic Tacrolimus Levels after Pediatric Heart Transplant Taylor, B.
 2013
 32 4S p. S293-
1 p.
 artikel
806 Tissue Evaluation of Donor Lungs Preserved with the Organ Care System (OCS) Device: Experience of Padova Calabrese, F.
 2013
 32 4S p. S155-
1 p.
 artikel
807 To Induce or Not To Induce: A 21st Century Evaluation of Lung Transplant Immunosuppression Whitson, B.A.
 2013
 32 4S p. S88-
1 p.
 artikel
808 Tranexamic Acid as Replacement Antifibrinolytic for Aprotinin – An Efficacy and Safety Study Ricky, H.
 2013
 32 4S p. S293-
1 p.
 artikel
809 Transapical Left Ventricular Vent (TLVV) during Artero-Venous ECMO Support: A Bridge to Solution in Acute Cardiogenic Shock Attisani, M.
 2013
 32 4S p. S230-S231
2 p.
 artikel
810 Transbronchial Brush (TBBr) Detection of Activated T Cells Identifies Patients at Risk of Progressive Bronchiolitis Obliterans Syndrome (BOS) Chambers, D.C.
 2013
 32 4S p. S104-
1 p.
 artikel
811 Transendothelial Migration of Leukocytes after Methylene Blue Treatment: Influence on Adhesion Molecules Kanzler, I.
 2013
 32 4S p. S297-
1 p.
 artikel
812 Transmyocardial Revascularization Enhances Mesenchymal Stem Cell Engraftment in Infarcted Hearts through SCF–c-Kit and SDF-1–CXCR4 Signaling Axes Shahzad, U.
 2013
 32 4S p. S68-
1 p.
 artikel
813 Transplantation of Initially Rejected Donor Lungs after Ex-Vivo Lung Perfusion Wallinder, A.
 2013
 32 4S p. S153-
1 p.
 artikel
814 Treatment of Secondary Pulmonary Hypertension with Bosentan after Left Ventricular Assist Device Implantation LaRue, S.J.
 2013
 32 4S p. S110-
1 p.
 artikel
815 Treatment Outcomes in Pulmonary Arterial Hypertension (PHA) Associated with Systemic Sclerosis (Sscl.) in Matched Groups Using Either Bosentan or Sildenafil Monotherapy Crackett, R.M.
 2013
 32 4S p. S301-
1 p.
 artikel
816 Treg Treatment Prevents Heart Allograft Vasculopathy in a Murine Mixed Chimerism Model Pilat, N.
 2013
 32 4S p. S69-
1 p.
 artikel
817 Trends in Hospital Charges for Heart Transplants in the United States Lee, P.H.U.
 2013
 32 4S p. S160-
1 p.
 artikel
818 Triage for Advanced Heart Failure: Effect of Regional Wait Time Disparity Kittleson, M.M.
 2013
 32 4S p. S166-S167
2 p.
 artikel
819 Tricuspid Regurgitation after Cardiac Transplantation Does Not Affect Long Term Survival Ferrara, A.
 2013
 32 4S p. S261-
1 p.
 artikel
820 Twenty Years Survivors after Heart Transplantation: La Pitié Experience Galeone, A.
 2013
 32 4S p. S14-
1 p.
 artikel
821 Two-Year Outcomes in the Destination Therapy Post-FDA-Approval Study with a Continuous Flow Left Ventricular Assist Device: A Prospective Study Using the INTERMACS Registry Jorde, U.P.
 2013
 32 4S p. S10-
1 p.
 artikel
822 Type and Extent of HLA Mismatch and Antibody-Mediated Rejection in Heart Transplantation Saidi, A.
 2013
 32 4S p. S86-
1 p.
 artikel
823 Type 2 Cardiorenal Syndrome in the Left Ventricular Assist Device (LVAD) Population Feitell, S.
 2013
 32 4S p. S227-
1 p.
 artikel
824 Unforeseen Events: Seizures Following Lung Transplant Henriksen, I.S.I.
 2013
 32 4S p. S139-
1 p.
 artikel
825 Unmarried Left Ventricular Assist Device (LVAD) Recipients Are More Likely To Experience Adverse Events Vader, J.M.
 2013
 32 4S p. S287-
1 p.
 artikel
826 Up-Scaling Decellularization and Whole Organ Culture for Human Lung Regeneration Gilpin, S.E.
 2013
 32 4S p. S69-S70
2 p.
 artikel
827 Use and Helpfulness of Interventions 5 and 10 Years after Heart Transplantation White-Williams, C.
 2013
 32 4S p. S81-
1 p.
 artikel
828 Use of Antibiotic Beads in the Treatment of Left Ventricular Assist Device Infections Kretlow, J.
 2013
 32 4S p. S276-
1 p.
 artikel
829 Use of Cylex Immune Monitoring Score To Guide Immunosuppression after Heart Transplantation Reduces Infection Risk Geft, D.
 2013
 32 4S p. S73-
1 p.
 artikel
830 Use of Genetic Testing for Targeted Anticoagulation in Patients on Long-Term Mechanical Circulatory Support Dewey, T.M.
 2013
 32 4S p. S12-
1 p.
 artikel
831 Use of Global Functional Index in the Assessment of Diastolic Dysfunction Nair, N.
 2013
 32 4S p. S163-S164
2 p.
 artikel
832 Use of Sirolimus in Lung Transplantation: A Single Center Experience Stuckey, L.J.
 2013
 32 4S p. S89-
1 p.
 artikel
833 Using Heart Failure Instruments To Determine When To Refer Heart Failure Patients to Palliative Care MacIver, J.
 2013
 32 4S p. S126-
1 p.
 artikel
834 Using 5-Year Survival Model Does Not Change LAS Estimate of Transplant Benefit Valapour, M.
 2013
 32 4S p. S120-
1 p.
 artikel
835 US Trends in Pediatric VAD Utilization: Analysis of Organ Procurement and Transplant Network Data Almond, C.S.
 2013
 32 4S p. S289-
1 p.
 artikel
836 Uteroglobin Protective Role in CLAD, from Proteomic to In Vitro Biological Activity Capuano, D.
 2013
 32 4S p. S103-
1 p.
 artikel
837 Utility of Bronchoalveolar Lavage Galactomannan in Diagnosis of Aspergillosis in Lung Transplant Recipients Birader, M.I.
 2013
 32 4S p. S47-S48
2 p.
 artikel
838 Utility of Electrocardiogram in the Assessment and Monitoring of Pediatric Pulmonary Hypertension Lau, K.C.
 2013
 32 4S p. S303-
1 p.
 artikel
839 Utility of Gene Expression Profiling Test (GEP) Score Instability To Predict Future Clinical Outcomes in Heart Transplant: Results from the CARGO 2 European-Based Multicenter Trial Crespo-Leiro, M.G.
 2013
 32 4S p. S113-S114
2 p.
 artikel
840 Utility of Gene Expression Profiling Test Score Stability To Predict Future Clinical Events in Heart Transplant Recipients Deng, M.C.
 2013
 32 4S p. S202-S203
2 p.
 artikel
841 Utility of Routine Right Heart Catheterization after LVAD Implantation Spiegelstein, D.
 2013
 32 4S p. S236-S237
2 p.
 artikel
842 Utility of Six-Minute Walk Distance in Predicting Outcomes after Lung Transplant: A Nationwide Survival Analysis Castleberry, A.W.
 2013
 32 4S p. S147-
1 p.
 artikel
843 Validation of Humoral Immunity Profiles To Identify Heart Recipients at Risk for Development of Severe Infections: A Multicenter Prospective Study Sarmiento, E.
 2013
 32 4S p. S73-
1 p.
 artikel
844 Venous Thromboembolic Events after Recombinant Activated Factor VII in Lung Transplant Recipients Iuppa, J.A.
 2013
 32 4S p. S215-
1 p.
 artikel
845 Ventricular Repolarization Dynamics and the Risk of Sudden Cardiac Death after Heart Transplantation Vrtovec, B.
 2013
 32 4S p. S212-
1 p.
 artikel
846 Virtual Crossmatch Predicts Compatibility for Heart Transplantation with Favorable Outcomes in Sensitized Patients Crowe, D.O.
 2013
 32 4S p. S86-S87
2 p.
 artikel
847 Weighted Gene Coexpression Network Analysis (WGCNA) Modeling of Multiorgan Dysfunction Syndrome after Mechanical Circulatory Support Therapy Wisniewski, N.
 2013
 32 4S p. S223-
1 p.
 artikel
848 Whole Blood Gene Expression of Multiorgan Dysfunction (MOD) after LVAD Implantation Bondar, G.
 2013
 32 4S p. S227-
1 p.
 artikel
849 WITHDRAWN 2013
 32 4S p. S231-
1 p.
 artikel
850 WITHDRAWN 2013
 32 4S p. S153-
1 p.
 artikel
851 WITHDRAWN 2013
 32 4S p. S81-
1 p.
 artikel
852 WITHDRAWN 2013
 32 4S p. S213-
1 p.
 artikel
853 WITHDRAWN 2013
 32 4S p. S106-
1 p.
 artikel
854 WITHDRAWN 2013
 32 4S p. S119-
1 p.
 artikel
855 World Wide Experience with Induction in Lung Transplantation for Cystic Fibrosis: Is Induction Necessary? Beaty, C.A.
 2013
 32 4S p. S90-
1 p.
 artikel
856 Worldwide Use of SynCardia Total Artificial Heart in Adolescents: A 25-Year Experience Morales, D.L.
 2013
 32 4S p. S109-
1 p.
 artikel
857 YKL-40 Production Is Increased in the Lung during Aspergillus Colonization and BOS after Lung Transplantation Weigt, S.S.
 2013
 32 4S p. S220-S221
2 p.
 artikel
858 You Are What You Eat: Impact of Early Metabolic Syndrome on Long-Term Outcome after Heart Transplantation Groemmer, M.
 2013
 32 4S p. S40-
1 p.
 artikel
                             858 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland